<!DOCTYPE html><html xmlns="http://www.w3.org/1999/xhtml" lang="en"><head><meta name="referrer" content="origin-when-crossorigin" /><script type="text/javascript" async="" src="https://www.gstatic.com/recaptcha/api2/r20160216085053/recaptcha__en.js"></script><script type="text/javascript">var clicks=[];var handleClicks=true;var handleUnready=function(e){if(!handleClicks){return}var n=e.target;while(n&amp;&amp;n.tagName&amp;&amp;n.tagName!="A"){n=n.parentNode}if(n&amp;&amp;n.getAttribute&amp;&amp;n.getAttribute("href")==="#"){clicks.push(e.target);var t=document.getElementById("async_spinner");if(!t){t=document.createElement("div");t.setAttribute("id","async_spinner");t.setAttribute("class","__live_spinner");var a=document.createElement("div");a.setAttribute("class","__live_spinner_indicator");require.enqueue(function(){var e=require("shared/spin").createSpinnerElement({color:"#fff"}).el;if(require("gating").toggle_loading_animation){e=require("shared/loading").createLoadingDotsElement({size:"small"})}a.appendChild(e);t.appendChild(a);document.body.appendChild(t)})}}};var clearHandlers=function(){if(!handleClicks){return}handleClicks=false;if(document.detachEvent){document.detachEvent("onclick",handleUnready)}else{document.removeEventListener("click",handleUnready,true)}for(var e=0;e&lt;clicks.length;++e){clicks[e].click()}var n=document.getElementById("async_spinner");if(n){n.parentNode.removeChild(n)}};if(document.attachEvent){document.attachEvent("onclick",handleUnready)}else{document.addEventListener("click",handleUnready,true)}
</script><link rel="search" type="application/opensearchdescription+xml" href="/opensearch/description.xml" title="Quora" /><meta name="robots" content="noarchive" /><link rel="next" href="/What-does-18-bp-deletion-in-exon-19-of-EGFR-gene-signify-in-a-patient-of-stage-4-adenocarcinoma-The-exon-21-shows-no-mutation-Can-the-tyrosine-kinase-inhibitors-be-used-in-such-a-patient?page_id=2" /><link rel="dns-prefetch" href="//qsc.is.quoracdn.net" /><link rel="dns-prefetch" href="//qph.is.quoracdn.net" /><link rel="dns-prefetch" href="//qsf.is.quoracdn.net" /><link rel="dns-prefetch" href="//connect.facebook.net" /><link rel="dns-prefetch" href="//apis.google.com" /><link rel="dns-prefetch" href="//static.ak.facebook.com" /><link rel="dns-prefetch" href="//cdn.mathjax.org" /><link rel="dns-prefetch" href="//maps.googleapis.com" /><link rel="dns-prefetch" href="//maps.gstatic.com" /><link href="https://qsc.is.quoracdn.net/-c27be6787a25ecce.css" rel="stylesheet" type="text/css" /><script type="text/javascript" src="https://qsc.is.quoracdn.net/-02051fe361f19eeb.js"></script><script type="text/javascript" src="https://qsc.is.quoracdn.net/-a20f7c1e8e7b7218.js" async="" defer=""></script><script type="text/javascript">
                if (window.log &amp;&amp; log.enabled)
                    log('page', 'Done. Header chunk is processed.');
            </script><title>What does 18 bp deletion in exon 19 of EGFR gene signify in a patient of stage 4 adenocarcinoma? The exon 21 shows no mutation. Can the tyrosine kinase inhibitors be used in such a patient? - Quora</title><link rel="canonical" href="https://www.quora.com/What-does-18-bp-deletion-in-exon-19-of-EGFR-gene-signify-in-a-patient-of-stage-4-adenocarcinoma-The-exon-21-shows-no-mutation-Can-the-tyrosine-kinase-inhibitors-be-used-in-such-a-patient" /><script type="text/javascript">
            if (window.w2_timing)
                w2_timing.logTime('bodyChunkStart');
            </script><style type="text/css"></style><style type="text/css" media="screen">#__w2_LpsbyJc_flash {visibility:hidden}</style></head><body class="web_page logged_out pretty_blogs gating-knows_about_suggestions-off gating-profile_overview-off gating-answers_profile-on gating-lookup_bar_grouped_results-off gating-offroad_force_slow_connection_mode-off gating-offroad_allow_slow_connection_mode-off gating-plato_question_page-off gating-plato_wide_header-off gating-qtext2_beta_group-off gating-toggle_loading_animation-on gating-qtext2_image_cursors-on gating-new_signup-off gating-quiet_notifs-off gating-plato_feed-off gating-plato_action_bar-off gating-new_answer_page-off gating-pretty_notifs-off"><script charset="utf-8" src="https://tch985800.tch.quora.com/up/chan24-8888/updates?min_seq=0&amp;channel=main-w-dep2508-658848286276270328&amp;timeout=2000&amp;callback=jsonp1531039fc08b75971b7"></script><script>
        
        require.install("gating", {client_side_logging: false,
feed_impression_feedback: false,
long_press: false,
mobile_a2a_ask_drawer: null,
enable_reading_time_logging: true,
queue_efficiency: false,
feed_edit_question: false,
batched_server_calls: true,
qtext2: true,
qtext2_beta_group: false,
cchannel_websockets: false,
toggle_loading_animation: true,
qtext2_auto_list: true,
qtext2_image_cursors: true,
qtext2_new_hr: true,
qtext2_unsaved_nav: true,
qtext2_oembedly: false,
first_nux_prompt: false,
new_answer_page: false,
enable_logging: true,
qtext2_whitespace_changes: true});
        
        require.install('settings', {"uid": null, "e2e_sample_rate": 0.1, "mobileRedirect": false, "formkey": "3785e7395124052d66321314ab71bd40", "isLoggedIn": false, "postkey": "4979c167accee3e858df2fabf7bf36e6", "save_feed_story_debug": false, "androidAppPackageName": "com.quora.android", "appURL": null, "interface_strings": {"ok": "OK", "in_progress_warning": "Warning: Your work in progress has not been saved. Leaving or reloading this page will discard any unsaved changes.", "please_refresh": "Please refresh this page to receive new updates.", "update": "Update", "trying_to_regain": "Trying to regain internet connection...", "done": "Done", "cancel": "Cancel"}, "enableFrameBusting": true, "serverCallUrl": "/webnode2/server_call_POST?__instart__", "pageIsMobile": false, "force_use_absolute_links": false, "debug": false, "instance": "main", "instart_cchannel_setting": false, "pageMode": "post_reload", "stripePublishableKey": "pk_live_QxYUG1mlWD0QqXWe57LN0MrY", "revision": "ee5e75c151aa5634f2c259bcccddbf9b146d2d3b", "googleClientId": "917071888555.apps.googleusercontent.com", "interfaceLanguage": "en", "nid": 0, "enableAccessToken": 0, "default_uri_subdomain_name": null, "controller": "question", "googleCookiePolicy": "http://quora.com", "cookiePrefix": "m", "fbAppId": "136609459636", "trail": null, "scribeSampleRate": 1, "isParallel": true, "client_side_server_call_error_logging_percentage": 0.0, "subdomain_name": null, "batchedServerCallUrl": "/webnode2/batched_server_call_POST?__instart__", "actionTrail": null, "speedStandard": {"owner": 21, "e2e": null, "server_side": 600, "server_side_goal": 350}, "action": "q", "keyboardShortcuts": false, "subdomain_suffix": "quora.com"});
        </script>
        <div class="InteractionModeBanner fade_out" id="__w2_Hd19Zf5_banner" style="display: none;"><div id="__w2_Hd19Zf5_message">This page may be out of date. <span class="hidden" id="__w2_Hd19Zf5_draftable"><a href="#" id="__w2_Hd19Zf5_resume">Save your draft</a> before refreshing this page.</span><span id="__w2_Hd19Zf5_not_draftable">Submit any pending changes before refreshing this page.</span></div></div><div class="ErrorBanner" id="__w2_Fc5WwL5_banner"><div id="__w2_Fc5WwL5_message"><span id="__w2_Fc5WwL5_text"></span> <a href="#" id="__w2_Fc5WwL5_hide">Hide this message</a>.</div></div><div class="modal_overlay hidden" id="__w2_modal_overlay_"><div class="modal_wrapper normal"><div id="__w2_modal_frame_placeholder_"></div></div></div><div id="ld_avoovn_11993"></div><div class="content_page_feed_offset"><div id="ld_avoovn_11995"><div class="SiteHeader LoggedOutSiteHeader" id="__w2_BzEECs8_header"><div class="header_inner"><div class="header_logo"><a href="/"><span>Quora</span></a></div><div class="signup_login_buttons"><div class="header_signin_with_search_bar action_button" id="__w2_BzEECs8_signup">Sign In</div></div><div class="header_search"><div class="search" id="__w2_BzEECs8_context_navigator"><div class="TypersearchESSelector LookupBarSelector ServerCallSelector Selector" id="__w2_XllMHlu_wrapper"><div class="selector_input_interaction"><input class="selector_input text" group="__w2_XllMHlu_interaction" type="text" autofocus="True" placeholder="Search for questions, people, and topics" value="" w2cid="XllMHlu" id="__w2_XllMHlu_input" /><div class="selector_spinner hidden" id="__w2_XllMHlu_spinner"><div class="LoadingDots tiny"><div class="dot first"></div><div class="dot second"></div><div class="dot third"></div></div></div></div><div class="lookup_bar_results_wrapper hidden" id="__w2_XllMHlu_results_wrapper"><div class="results_wrapper"><div class="hidden resistance_wrapper" id="__w2_XllMHlu_server_message"></div><div class="interstitials_and_results"><div class="hidden ask_interstitial" id="__w2_XllMHlu_ask_mode_interstitial"><p class="ask_interstitial_content"><strong class="ask_interstitial_title" id="__w2_XllMHlu_interstitial_title"></strong><span id="__w2_XllMHlu_interstitial_text"></span></p></div><div class="results" id="__w2_XllMHlu_results"></div></div></div></div></div></div></div></div></div></div><div id="__w2_HOMEQCR_body_blur"></div><div id="ld_avoovn_11996"><div class="PMsgContainer" id="__w2_TLtFbwM_pmsg_container"></div><div class="ContentWrapper"><div id="__w2_lXDZyoW_content"><div id="ld_shnakz_78717"><div class="QuestionPageBanners"><div id="ld_ciryxk_76672"></div><div id="ld_ciryxk_76673"></div><div id="ld_ciryxk_76674"></div><div id="ld_ciryxk_76675"></div><div id="ld_ciryxk_76676"></div></div><div class="NewGridQuestionPage QuestionMain"><div class="grid_page"><div class="layout_2col_main"><div class="header"><div id="ld_ciryxk_76671"><div class="QuestionArea"><div id="ld_wmdaha_74172"><div class="QuestionTopicHorizontalList TopicList" id="__w2_FnjG1fn_topics_list"><div id="ld_qiqlfz_67807"><div class="QuestionTopicListItems SimpleToggle TopicListItems2 Toggle QuestionTopicHorizontalListItems" id="__w2_a9T4m6z__truncated"><span id="ld_xphvvh_71004"><div class="QuestionTopicListItem TopicListItem topic_pill" id="__w2_IMftZeq_topic_list_item"><a class="topic_remove" href="#" id="__w2_IMftZeq_remove_topic"></a><div id="ld_xphvvh_71009"><div class="hover_menu hidden white_bg show_nub" id="__w2_Cm83j8W_menu"><div class="hover_menu_contents" id="__w2_Cm83j8W_menu_contents"> </div></div><a class="TopicNameLink HoverMenu topic_name" href="/topic/Tyrosine-Kinases" target="" action_mousedown="TopicLinkClickthrough" id="__w2_Cm83j8W_link"><span class="name_text"><span id="ld_xphvvh_71014"><span class="TopicNameSpan TopicName">Tyrosine Kinases</span></span></span></a></div></div></span><span id="ld_xphvvh_71005"><div class="QuestionTopicListItem TopicListItem topic_pill" id="__w2_axxxHc0_topic_list_item"><a class="topic_remove" href="#" id="__w2_axxxHc0_remove_topic"></a><div id="ld_xphvvh_71010"><div class="hover_menu hidden white_bg show_nub" id="__w2_PsWd8ei_menu"><div class="hover_menu_contents" id="__w2_PsWd8ei_menu_contents"> </div></div><a class="TopicNameLink HoverMenu topic_name" href="/topic/Cancer-Treatment" target="" action_mousedown="TopicLinkClickthrough" id="__w2_PsWd8ei_link"><span class="name_text"><span id="ld_xphvvh_71015"><span class="TopicNameSpan TopicName">Cancer Treatment</span></span></span></a></div></div></span><span id="ld_xphvvh_71006"><div class="QuestionTopicListItem TopicListItem topic_pill" id="__w2_DgzKYMv_topic_list_item"><a class="topic_remove" href="#" id="__w2_DgzKYMv_remove_topic"></a><div id="ld_xphvvh_71011"><div class="hover_menu hidden white_bg show_nub" id="__w2_ENGc9F8_menu"><div class="hover_menu_contents" id="__w2_ENGc9F8_menu_contents"> </div></div><a class="TopicNameLink HoverMenu topic_name" href="/topic/Cancer" target="" action_mousedown="TopicLinkClickthrough" id="__w2_ENGc9F8_link"><span class="name_text"><span id="ld_xphvvh_71016"><span class="TopicNameSpan TopicName">Cancer</span></span></span></a></div></div></span><span id="ld_xphvvh_71007"><div class="QuestionTopicListItem TopicListItem topic_pill" id="__w2_itUB0av_topic_list_item"><a class="topic_remove" href="#" id="__w2_itUB0av_remove_topic"></a><div id="ld_xphvvh_71012"><div class="hover_menu hidden white_bg show_nub" id="__w2_wh85suQ_menu"><div class="hover_menu_contents" id="__w2_wh85suQ_menu_contents"> </div></div><a class="TopicNameLink HoverMenu topic_name" href="/topic/Biochemistry" target="" action_mousedown="TopicLinkClickthrough" id="__w2_wh85suQ_link"><span class="name_text"><span id="ld_xphvvh_71017"><span class="TopicNameSpan TopicName">Biochemistry</span></span></span></a></div></div></span><span id="ld_xphvvh_71008"><div class="QuestionTopicListItem TopicListItem topic_pill" id="__w2_WyQHWyA_topic_list_item"><a class="topic_remove" href="#" id="__w2_WyQHWyA_remove_topic"></a><div id="ld_xphvvh_71013"><div class="hover_menu hidden white_bg show_nub" id="__w2_tTdLROG_menu"><div class="hover_menu_contents" id="__w2_tTdLROG_menu_contents"> </div></div><a class="TopicNameLink HoverMenu topic_name" href="/topic/Medicine-and-Healthcare" target="" action_mousedown="TopicLinkClickthrough" id="__w2_tTdLROG_link"><span class="name_text"><span id="ld_xphvvh_71018"><span class="TopicNameSpan TopicName">Medicine and Healthcare</span></span></span></a></div></div></span></div></div></div></div><div id="ld_wmdaha_74173"><div class="question_text_edit"><h1><span id="ld_wmdaha_74175"><span id="ld_wmdaha_74176"></span><span id="__w2_MwCObfX_question_text"><span class="rendered_qtext">What does 18 bp deletion in exon 19 of EGFR gene signify in a patient of stage 4 adenocarcinoma? The exon 21 shows no mutation. Can the tyrosine kinase inhibitors be used in such a patient?</span></span></span></h1></div></div><div id="ld_wmdaha_74174"><div class="question_details"><div class="question_details_text inline_editor_content"><span class="rendered_qtext"></span></div></div></div><div class="form_buttons hidden shared_form" id="__w2_LLyadbl_details_container"><a class="submit_button" id="__w2_LLyadbl_question_update">Update</a><a class="cancel_button" id="__w2_LLyadbl_question_cancel">Cancel</a></div></div></div></div><div id="ld_ciryxk_76670"><div id="ld_ihqyxl_68010"><div class="AnswerWikiArea hidden" id="answer_wiki"><h3>Answer Wiki</h3><div id="ld_ihqyxl_68016"><div id="__w2_aayysJ0_wiki"><span class="rendered_qtext"></span></div></div></div></div><div id="ld_ihqyxl_68011"><div class="QuestionPageAnswerHeader"><div class="answer_count">2 Answers<span class="writing_now_section"><span id="ld_ihqyxl_68014"></span></span></div></div></div><div id="ld_ihqyxl_68012"></div><a class="anchor" name="answers" id="__w2_YAR0aK1_answers_anchor" style="top: -53px;"></a><div class="AnswerListDiv" id="__w2_YAR0aK1_answers"><div class="AnswerPagedList PagedList" tabindex="-1" id="ld_ihqyxl_68015"><div class="pagedlist_item" tabindex="-1" id="ld_jzckxs_73201"><div id="ld_hobndj_73571"><div id="__w2_rzhG6vF_actionable"><div id="ld_udhbbd_68333"><div id="ld_udhbbd_68334"><a name="answer_14458715" target="_blank"></a><div class="Answer AnswerBase" id="__w2_e2HlV0l_answer"><div><div id="ld_jjjtlr_70610"><div class="AnswerHeader ContentHeader"><div id="ld_xmhwjp_70443"><div class="hover_menu hidden white_bg show_nub" id="__w2_aOkuXmR_menu"><div class="hover_menu_contents" id="__w2_aOkuXmR_menu_contents"> </div></div><span class="photo_tooltip" id="__w2_aOkuXmR_link"><a href="/profile/H-Jack-West" id="__w2_KE0m9vE_link" target="_blank"><img class="profile_photo_img" src="https://qsf.is.quoracdn.net/-7405df969246c5e8.png" height="50" width="50" data-src="https://qph.is.quoracdn.net/main-thumb-5010980-50-rwW9qPFtEi2reaOqhm81IHkGMwXb8o5m.jpeg" alt="H. Jack West" /></a><span id="ld_xmhwjp_70446"></span></span></div><span class="feed_item_answer_user"><span id="ld_xmhwjp_70444"><div class="hover_menu hidden white_bg show_nub" id="__w2_sXZST77_menu"><div class="hover_menu_contents" id="__w2_sXZST77_menu_contents"> </div></div><a class="user" href="/profile/H-Jack-West" action_mousedown="UserLinkClickthrough" id="__w2_sXZST77_link" target="_blank">H. Jack West</a><span class="IdentitySig ActorNameSig IdentityNameSig" id="__w2_PoeIP4Z_bio">, <span id="__w2_PoeIP4Z_link"><span class="IdentitySig ActorNameSig IdentityNameSig" id="__w2_PoeIP4Z_sig"><span class="expanded_q_text" id="__w2_VA5cSFB_text_snip"><span id="__w2_VA5cSFB_text_snip_content"><span class="rendered_qtext">Seattle-Based Medical Oncologist, Twitter: @JackWestMD, Founder: CancerGRACE.org</span></span></span></span></span></span></span></span><div class="credibility_facts"><div id="ld_xmhwjp_70445"><div class="CredibilityFact">207 Views<span class="bullet"> • </span><div class="hover_menu hidden white_bg show_nub" id="__w2_F0Z9Gir_menu"><div class="hover_menu_contents" id="__w2_F0Z9Gir_menu_contents"> </div></div><a class="user" href="/profile/H-Jack-West" action_mousedown="UserLinkClickthrough" id="__w2_F0Z9Gir_link" target="_blank">H. Jack</a> has <a href="/profile/H-Jack-West/answers/Cancer" target="_blank">30+ answers</a> in <div class="hover_menu hidden white_bg show_nub" id="__w2_GYSl6Cv_menu"><div class="hover_menu_contents" id="__w2_GYSl6Cv_menu_contents"> </div></div><a class="TopicNameLink HoverMenu topic_name" href="/topic/Cancer" target="_blank" action_mousedown="TopicLinkClickthrough" id="__w2_GYSl6Cv_link"><span class="name_text"><span id="ld_ihqyxl_68017"><span class="TopicNameSpan TopicName">Cancer</span></span></span></a>.</div></div></div></div></div><div id="__w2_e2HlV0l_answer_content"><div id="ld_jjjtlr_70611"></div><div id="ld_jjjtlr_70612"></div><div id="ld_jjjtlr_70613"><div class="ExpandedQText ExpandedAnswer" id="__w2_c8cvoxw_expanded"><span class="rendered_qtext">Yes, an exon 19 deletion is associated with a 60-75% chance of significant tumor shrinkage, and of the common activating mutations (exon 19 deletions or L858R substitution on exon 21), exon 19 mutations are often found to be associated with a longer time to progression and longer overall survival, though exon 21 mutations are still favorable compared to not having a driver mutation. <br /><br />Afatinib (Gilotrif or Giotrif, depending on what part of the world you're in) has been shown to be associated with an improvement in overall survival of &gt;12 months compared with standard chemotherapy as first line therapy for patients with an exon 19 deletion. This may be unique to Gilotrif -- other commonly used EGFR tyrosine kinase inhibitors (TKIs) such as gefitinib (Iressa) and erlotinib (Tarceva) have generally shown comparable efficacy in terms of response rates and progression-free survival, but there haven't been studies as large as the ones with Gilotrif, and we haven't seen a similar survival benefit vs. chemo with them.  <br /><br />We await trials of one EGFR TKI vs. another to help us determine whether afatinib is better for exon 19 patients (it showed a strong trend toward a worse survival vs. chemo in patients with an exon 21 mutation, so I would be quite disinclined to recommend it for them) or whether all of the EGFR TKIs are really overwhelmingly similar in efficacy for patients with the same mutations, perhaps more different in side effect profile than anything else (Gilotrif most challenging, Iressa best tolerated, Tarceva in between based on the profiles seen in many trials).  <br /><br />One other option for patients with an activating EGFR mutation, and the one I happen to favor most, is the combination of Tarceva with bevacizumab (Avastin). In a Japanese trial of 152 patients with advanced NSCLC and an activating EGFR mutation who were previously untreated and randomized to either Tarceva alone or Tarceva/Avastin (published by Seto and colleagues in Lancet Oncology, 2014), those receiving the combination had a median progression-free survival more than 6 months longer than those receiving Tarceva alone, and they also showed a trend toward better overall survival (most of the patients were still alive on both arms, so it's not possible to say anything more definitive). But this difference of  more than 6 months is very impressive and was seen for both exon 19 and exon 21 patients. <br /><br />While it's not yet a clear standard of care, I try to get Avastin along with Tarceva for my own patients based on this compelling evidence, and I've had far more success than not in getting it covered. Many experts prefer corroborating evidence from a non-Japanese trial, but I'm struck that the lung cancer community has often changed our standard of care based on much weaker evidence; I think the reluctance is mostly just a bias, perhaps largely influenced by the cost of Avastin, which is significant.  However, it's fair to say that the EGFR TKI portion is the ironclad part of the treatment, with the potential value of Avastin along with it as a judgment call.</span><div id="ld_jtrrlm_70066"><div class="ContentFooter AnswerFooter" id="__w2_idJMrOX_content_footer"><span id="ld_shnakz_78719"><a class="answer_permalink" href="/What-does-18-bp-deletion-in-exon-19-of-EGFR-gene-signify-in-a-patient-of-stage-4-adenocarcinoma-The-exon-21-shows-no-mutation-Can-the-tyrosine-kinase-inhibitors-be-used-in-such-a-patient/answer/H-Jack-West" action_mousedown="AnswerPermalinkClickthrough" id="__w2_IOas4bp_link" target="_blank">Written Aug 1, 2015</a></span><span class="bullet"> • </span><a class="AnswerVoterListModalLink VoterListModalLink" href="/api/mobile_expanded_voter_list?type=answer&amp;key=9GTot439z4A" id="__w2_IBRzVti_modal_link" target="_blank">View Upvotes</a><span id="ld_shnakz_78720"></span><span class="AnswerAttributionSection"><span class="bullet"> • </span>Asked to answer by <div class="hover_menu hidden white_bg show_nub" id="__w2_zUmESsG_menu"><div class="hover_menu_contents" id="__w2_zUmESsG_menu_contents"> </div></div><a class="user" href="/profile/Abhishek-Chanda" action_mousedown="UserLinkClickthrough" id="__w2_zUmESsG_link" target="_blank">Abhishek Chanda</a></span></div></div></div></div></div></div></div></div></div></div></div></div><div class="pagedlist_item" tabindex="-1" id="ld_jzckxs_73202"><div id="ld_odibui_70435"><div class="w4_5"><div class="logged_out_related_questions_container"><div class="logged_out_related_questions_heading"><h4>Related Questions</h4><div class="more_questions_text"><a href="#MoreAnswers">More Answers Below</a></div><div class="inline_related"><div class="question_related list"><ul class="list_contents"><li class="related_question"><div id="__w2_msGHAEE_actionable"><div id="ld_klfoee_70993"><a class="question_link" href="/What-is-Bruton’s-Tyrosine-Kinase-signaling" target="_blank" action_mousedown="QuestionLinkClickthrough" id="__w2_VnxZBBD_link"><span class="question_text"><span id="ld_klfoee_70998"></span><span class="rendered_qtext">What is Bruton’s Tyrosine Kinase signaling?</span></span></a></div></div></li><li class="related_question"><div id="__w2_Tdt30LI_actionable"><div id="ld_klfoee_70994"><a class="question_link" href="/Are-new-PD1-drugs-Mercks-PD-1-Inhibitor-Keytruda-or-Ono-Pharmaceuticals-nivolumab-effective-against-advanced-stage-adenocarcinoma-stage-4-b-of-gall-bladder" target="_blank" action_mousedown="QuestionLinkClickthrough" id="__w2_yNgeMMP_link"><span class="question_text"><span id="ld_klfoee_70999"></span><span class="rendered_qtext">Are new PD1 drugs (Merck's PD-1 Inhibitor, Keytruda or Ono Pharmaceutical's nivolumab) effective against advanced stage adenocarcinoma (stage ...</span></span></a></div></div></li><li class="related_question"><div id="__w2_bGXbcIe_actionable"><div id="ld_klfoee_70995"><a class="question_link" href="/What-are-the-best-treatment-options-Main-Stream-and-Alternative-for-Stage-4-Gall-Bladder-adenocarcinoma-Cancer" target="_blank" action_mousedown="QuestionLinkClickthrough" id="__w2_hBJJwuF_link"><span class="question_text"><span id="ld_klfoee_71000"></span><span class="rendered_qtext">What are the best treatment options (Main Stream and Alternative) for Stage 4 Gall Bladder adenocarcinoma Cancer?</span></span></a></div></div></li><li class="related_question"><div id="__w2_wOt8Psp_actionable"><div id="ld_klfoee_70996"><a class="question_link" href="/Can-exon-skipping-cure-all-mutations" target="_blank" action_mousedown="QuestionLinkClickthrough" id="__w2_wj6xKGt_link"><span class="question_text"><span id="ld_klfoee_71001"></span><span class="rendered_qtext">Can exon skipping "cure" all mutations?</span></span></a></div></div></li><li class="related_question"><div id="__w2_pnLTeif_actionable"><div id="ld_klfoee_70997"><a class="question_link" href="/Patients/Is-it-naive-to-ask-too-many-questions-about-Lab-reports-from-a-doctor" target="_blank" action_mousedown="QuestionLinkClickthrough" id="__w2_EozIeYc_link"><span class="question_text"><span id="ld_klfoee_71002"><span class="question_context"><span id="ld_klfoee_71003"><span class="TopicNameSpan TopicName">Patients</span></span><span class="normal">:</span> </span></span><span class="rendered_qtext"><div class="qtext_para">Is it naive to ask too many questions about Lab reports from a doctor?</div></span></span></a></div></div></li></ul></div></div></div></div></div></div></div><div class="pagedlist_item" tabindex="-1" id="ld_jzckxs_73203"><div id="ld_izkhvb_69986"><div id="__w2_G0A5av7_actionable"><div id="ld_ruweyh_71466"><a class="anchor" name="MoreAnswers" target="_blank"></a><div id="ld_ruweyh_71467"><a name="answer_14458033" target="_blank"></a><div class="Answer AnswerBase" id="__w2_cIoKsMy_answer"><div><div id="ld_nnggfb_71093"><div class="AnswerHeader ContentHeader"><div id="ld_nuthnv_74219"><div class="hover_menu hidden white_bg show_nub" id="__w2_CB0mH7Z_menu"><div class="hover_menu_contents" id="__w2_CB0mH7Z_menu_contents"> </div></div><span class="photo_tooltip" id="__w2_CB0mH7Z_link"><a href="/profile/Chris-Heery" id="__w2_oY4kaDI_link" target="_blank"><img class="profile_photo_img" src="https://qsf.is.quoracdn.net/-7405df969246c5e8.png" height="50" width="50" data-src="https://qph.is.quoracdn.net/main-thumb-554801-50-C6Gx9GanvpJCpiN70H0gAB8Bidf08lwn.jpeg" alt="Chris Heery" /></a><span id="ld_nuthnv_74222"></span></span></div><span class="feed_item_answer_user"><span id="ld_nuthnv_74220"><div class="hover_menu hidden white_bg show_nub" id="__w2_oXiLx8K_menu"><div class="hover_menu_contents" id="__w2_oXiLx8K_menu_contents"> </div></div><a class="user" href="/profile/Chris-Heery" action_mousedown="UserLinkClickthrough" id="__w2_oXiLx8K_link" target="_blank">Chris Heery</a><span class="IdentitySig ActorNameSig IdentityNameSig" id="__w2_kXj1Flk_bio">, <span id="__w2_kXj1Flk_link"><span class="IdentitySig ActorNameSig IdentityNameSig" id="__w2_kXj1Flk_sig"><span class="expanded_q_text" id="__w2_zmDRHWU_text_snip"><span id="__w2_zmDRHWU_text_snip_content"><span class="rendered_qtext">Medical Oncology Researcher, focused on tumor immunology</span></span></span></span></span></span></span></span><div class="credibility_facts"><div id="ld_nuthnv_74221"><div class="CredibilityFact">51 Views</div></div></div></div></div><div id="__w2_cIoKsMy_answer_content"><div id="ld_nnggfb_71094"></div><div id="ld_nnggfb_71095"></div><div id="ld_nnggfb_71096"><div class="ExpandedQText ExpandedAnswer" id="__w2_c8yaR92_expanded"><span class="rendered_qtext">Absolutely. The location of the BP deletion may impact likelihood of response, but the clinically approved tests can answer likelihood of response now. <br /><br />In general, though, exon 19 mutations are associated with very favorable outcomes using erlotinib.  <br /><br />Ref: Jackman CCR 2006</span><div id="ld_nxqroq_71817"><div class="ContentFooter AnswerFooter" id="__w2_uH1CStN_content_footer"><span id="ld_ciryxk_76678"><a class="answer_permalink" href="/What-does-18-bp-deletion-in-exon-19-of-EGFR-gene-signify-in-a-patient-of-stage-4-adenocarcinoma-The-exon-21-shows-no-mutation-Can-the-tyrosine-kinase-inhibitors-be-used-in-such-a-patient/answer/Chris-Heery" action_mousedown="AnswerPermalinkClickthrough" id="__w2_HpaYcRU_link" target="_blank">Written Aug 1, 2015</a></span><span class="bullet"> • </span><a class="AnswerVoterListModalLink VoterListModalLink" href="/api/mobile_expanded_voter_list?type=answer&amp;key=RRU2ucmCZSD" id="__w2_bVz5PGF_modal_link" target="_blank">View Upvotes</a><span id="ld_ciryxk_76679"></span><span class="AnswerAttributionSection"><span class="bullet"> • </span>Asked to answer by <div class="hover_menu hidden white_bg show_nub" id="__w2_YfE0GoW_menu"><div class="hover_menu_contents" id="__w2_YfE0GoW_menu_contents"> </div></div><a class="user" href="/profile/Abhishek-Chanda" action_mousedown="UserLinkClickthrough" id="__w2_YfE0GoW_link" target="_blank">Abhishek Chanda</a></span></div></div></div></div></div></div></div></div></div></div></div></div><div class="pagedlist_item" tabindex="-1" id="ld_jzckxs_73204"><div id="ld_dnjbfs_73537"><div id="__w2_S8Wnt3v_actionable"><div id="ld_iyimpg_68945"><div id="ld_iyimpg_68946"><div class="CollapsedAnswersSectionCollapsed SimpleToggle Toggle" id="__w2_c0X55t7__truncated"></div><div class="CollapsedAnswersSectionCollapsed SimpleToggle Toggle hidden" id="__w2_c0X55t7__expanded"></div></div></div></div></div></div><div id="ld_jzckxs_73205"><div class="pager_next" id="__w2_QwEYFYu_loading"><div class="__wn2_loading"><span class="__wn2_loading_spinner"></span></div></div><div class="pager_next action_button row hidden" id="__w2_QwEYFYu_more" style="display: none;">View More Answers</div><div class="pager_sentinel" id="__w2_QwEYFYu_sentinel"></div></div></div></div><div id="ld_ihqyxl_68013"><div class="w4_5"><div class="logged_out_related_questions_container"><div class="logged_out_related_questions_heading"><h4>Related Questions</h4><div class="question_related list"><ul class="list_contents"><li class="related_question"><div id="__w2_uXOd2Y7_actionable"><div id="ld_cxmgem_64405"><a class="question_link" href="/Aging/How-do-tyrosine-kinase-inhibitors-affect-lifespan" target="_blank" action_mousedown="QuestionLinkClickthrough" id="__w2_TCLjGD3_link"><span class="question_text"><span id="ld_cxmgem_64426"><span class="question_context"><span id="ld_cxmgem_64435"><span class="TopicNameSpan TopicName">Aging</span></span><span class="normal">:</span> </span></span><span class="rendered_qtext">How do tyrosine kinase inhibitors affect lifespan?</span></span></a></div></div></li><li class="related_question"><div id="__w2_Y0Eu4E5_actionable"><div id="ld_cxmgem_64406"><a class="question_link" href="/Biochemistry/What-are-the-drawbacks-of-tyrosine-kinase-inhibitors" target="_blank" action_mousedown="QuestionLinkClickthrough" id="__w2_FUmZUrN_link"><span class="question_text"><span id="ld_cxmgem_64427"><span class="question_context"><span id="ld_cxmgem_64436"><span class="TopicNameSpan TopicName">Biochemistry</span></span><span class="normal">:</span> </span></span><span class="rendered_qtext">What are the drawbacks of tyrosine-kinase inhibitors?</span></span></a></div></div></li><li class="related_question"><div id="__w2_TrNUy64_actionable"><div id="ld_cxmgem_64407"><a class="question_link" href="/How-is-PCR-used-to-detect-gene-mutation-in-the-case-of-a-suspected-cancer-patient" target="_blank" action_mousedown="QuestionLinkClickthrough" id="__w2_e05Cu2s_link"><span class="question_text"><span id="ld_cxmgem_64420"></span><span class="rendered_qtext">How is PCR used to detect gene mutation in the case of a suspected cancer patient?</span></span></a></div></div></li><li class="related_question"><div id="__w2_zl65tZS_actionable"><div id="ld_cxmgem_64408"><a class="question_link" href="/Can-two-different-cancer-patients-have-the-same-gene-mutation" target="_blank" action_mousedown="QuestionLinkClickthrough" id="__w2_MFNMqdj_link"><span class="question_text"><span id="ld_cxmgem_64421"></span><span class="rendered_qtext">Can two different cancer patients have the same gene mutation?</span></span></a></div></div></li><li class="related_question"><div id="__w2_DEn58CI_actionable"><div id="ld_cxmgem_64409"><a class="question_link" href="/Can-stage-4-kidney-patient-take-colace" target="_blank" action_mousedown="QuestionLinkClickthrough" id="__w2_jnyv3re_link"><span class="question_text"><span id="ld_cxmgem_64422"></span><span class="rendered_qtext">Can stage 4 kidney patient take colace?</span></span></a></div></div></li><li class="related_question"><div id="__w2_BVsB405_actionable"><div id="ld_cxmgem_64410"><a class="question_link" href="/unanswered/Patient-Engagement/What-types-of-services-does-emmi-provide" target="_blank" action_mousedown="QuestionLinkClickthrough" id="__w2_shPodUD_link"><span class="question_text"><span id="ld_cxmgem_64428"><span class="question_context"><span id="ld_cxmgem_64437"><span class="TopicNameSpan TopicName">Patient Engagement</span></span><span class="normal">:</span> </span></span><span class="rendered_qtext">What types of services does emmi provide?</span></span></a></div></div></li><li class="related_question"><div id="__w2_MhADZYb_actionable"><div id="ld_cxmgem_64411"><a class="question_link" href="/Are-there-any-clinical-literature-demonstrating-patients-with-homozygous-CCR5-Delta-32-gene-mutation-deletion-have-acquired-HIV-and-which-strains-still-remain-infectious-to-those-with-mutation" target="_blank" action_mousedown="QuestionLinkClickthrough" id="__w2_CLEydCq_link"><span class="question_text"><span id="ld_cxmgem_64423"></span><span class="rendered_qtext">Are there any clinical literature demonstrating patients with homozygous CCR5 Delta 32 gene mutation deletion have acquired HIV and which stra...</span></span></a></div></div></li><li class="related_question"><div id="__w2_WVJVSO6_actionable"><div id="ld_cxmgem_64412"><a class="question_link" href="/unanswered/Biochemistry/How-do-the-effects-of-GRB2-inhibitors-differ-from-those-of-receptor-tyrosine-kinase-inhibitors" target="_blank" action_mousedown="QuestionLinkClickthrough" id="__w2_Vba7irz_link"><span class="question_text"><span id="ld_cxmgem_64429"><span class="question_context"><span id="ld_cxmgem_64438"><span class="TopicNameSpan TopicName">Biochemistry</span></span><span class="normal">:</span> </span></span><span class="rendered_qtext">How do the effects of GRB2 inhibitors differ from those of receptor tyrosine kinase inhibitors?</span></span></a></div></div></li><li class="related_question"><div id="__w2_M3BEqdw_actionable"><div id="ld_cxmgem_64413"><a class="question_link" href="/Can-a-BP-patient-use-diclofenac-sodium-tablet" target="_blank" action_mousedown="QuestionLinkClickthrough" id="__w2_RoIvJm3_link"><span class="question_text"><span id="ld_cxmgem_64424"></span><span class="rendered_qtext">Can a BP patient use diclofenac sodium tablet?</span></span></a></div></div></li><li class="related_question"><div id="__w2_robneA3_actionable"><div id="ld_cxmgem_64414"><a class="question_link" href="/Src-Gene/How-does-Src-inhibitor-PP2-work" target="_blank" action_mousedown="QuestionLinkClickthrough" id="__w2_D7cxk13_link"><span class="question_text"><span id="ld_cxmgem_64430"><span class="question_context"><span id="ld_cxmgem_64439"><span class="TopicNameSpan TopicName">Src Gene</span></span><span class="normal">:</span> </span></span><span class="rendered_qtext">How does Src inhibitor PP2 work?</span></span></a></div></div></li><li class="related_question"><div id="__w2_JrcpmkR_actionable"><div id="ld_cxmgem_64415"><a class="question_link" href="/Obamacare-Patient-Protection-and-Affordable-Care-Act/How-will-ACA-affect-career-and-job-choices-of-young-people-and-their-lives-in-general" target="_blank" action_mousedown="QuestionLinkClickthrough" id="__w2_nCDHgxU_link"><span class="question_text"><span id="ld_cxmgem_64431"><span class="question_context"><span id="ld_cxmgem_64440"><span class="TopicNameSpan TopicName">Obamacare (Patient Protection and Affordable Care Act)</span></span><span class="normal">:</span> </span></span><span class="rendered_qtext">How will ACA affect career and job choices of young people, and their lives in general?</span></span></a></div></div></li><li class="related_question"><div id="__w2_V4JBCsi_actionable"><div id="ld_cxmgem_64416"><a class="question_link" href="/unanswered/Can-high-bp-patients-do-Surya-namaskaras" target="_blank" action_mousedown="QuestionLinkClickthrough" id="__w2_qbeADnN_link"><span class="question_text"><span id="ld_cxmgem_64425"></span><span class="rendered_qtext">Can high bp patients do Surya namaskaras?</span></span></a></div></div></li><li class="related_question"><div id="__w2_ZuqiVNM_actionable"><div id="ld_cxmgem_64417"><a class="question_link" href="/Obamacare-Patient-Protection-and-Affordable-Care-Act/Are-there-caps-or-limits-on-heath-insurance-company-liabilities-under-the-ACA" target="_blank" action_mousedown="QuestionLinkClickthrough" id="__w2_BarWVM3_link"><span class="question_text"><span id="ld_cxmgem_64432"><span class="question_context"><span id="ld_cxmgem_64441"><span class="TopicNameSpan TopicName">Obamacare (Patient Protection and Affordable Care Act)</span></span><span class="normal">:</span> </span></span><span class="rendered_qtext">Are there caps or limits on heath insurance company liabilities under the ACA?</span></span></a></div></div></li><li class="related_question"><div id="__w2_t612flh_actionable"><div id="ld_cxmgem_64418"><a class="question_link" href="/Obamacare-Patient-Protection-and-Affordable-Care-Act/Is-the-ACA-i-e-Obamacare-actually-socialist" target="_blank" action_mousedown="QuestionLinkClickthrough" id="__w2_alo73QX_link"><span class="question_text"><span id="ld_cxmgem_64433"><span class="question_context"><span id="ld_cxmgem_64442"><span class="TopicNameSpan TopicName">Obamacare (Patient Protection and Affordable Care Act)</span></span><span class="normal">:</span> </span></span><span class="rendered_qtext">Is the ACA (i.e., Obamacare) actually socialist?</span></span></a></div></div></li><li class="related_question"><div id="__w2_X3iT7Uu_actionable"><div id="ld_cxmgem_64419"><a class="question_link" href="/Obamacare-Patient-Protection-and-Affordable-Care-Act/How-are-primary-care-physicians-affected-by-ACA" target="_blank" action_mousedown="QuestionLinkClickthrough" id="__w2_KDM6ZTL_link"><span class="question_text"><span id="ld_cxmgem_64434"><span class="question_context"><span id="ld_cxmgem_64443"><span class="TopicNameSpan TopicName">Obamacare (Patient Protection and Affordable Care Act)</span></span><span class="normal">:</span> </span></span><span class="rendered_qtext">How are primary care physicians affected by ACA?</span></span></a></div></div></li></ul></div></div></div></div></div></div></div><div class="layout_2col_side"><div id="__w2_x0tgB0l_actions"><div id="__w2_XAVbQ6Y_related_questions"><div id="ld_ciryxk_76677"><div class="SimpleToggle RelatedQuestions Toggle" id="__w2_RLntjJQ__truncated"><div class="SimpleToggle RelatedQuestions Toggle"><div id="__w2_RLntjJQ_related_questions"><h3>Related Questions</h3><div class="question_related list"><ul class="list_contents"><li class="related_question"><div id="__w2_zvr4bNz_actionable"><div id="ld_ktzliu_74352"><a class="question_link" href="/What-is-Bruton’s-Tyrosine-Kinase-signaling" target="_blank" action_mousedown="QuestionLinkClickthrough" id="__w2_nRAOZUg_link"><span class="question_text"><span id="ld_ktzliu_74362"></span><span class="rendered_qtext">What is Bruton’s Tyrosine Kinase signaling?</span></span></a></div></div></li><li class="related_question"><div id="__w2_hzNrTQZ_actionable"><div id="ld_ktzliu_74353"><a class="question_link" href="/Are-new-PD1-drugs-Mercks-PD-1-Inhibitor-Keytruda-or-Ono-Pharmaceuticals-nivolumab-effective-against-advanced-stage-adenocarcinoma-stage-4-b-of-gall-bladder" target="_blank" action_mousedown="QuestionLinkClickthrough" id="__w2_nvTenLj_link"><span class="question_text"><span id="ld_ktzliu_74363"></span><span class="rendered_qtext">Are new PD1 drugs (Merck's PD-1 Inhibitor, Keytruda or Ono Pharmaceutical's nivolumab) effective against advanced stage adenocarcinoma (stage ...</span></span></a></div></div></li><li class="related_question"><div id="__w2_gqNlpIZ_actionable"><div id="ld_ktzliu_74354"><a class="question_link" href="/What-are-the-best-treatment-options-Main-Stream-and-Alternative-for-Stage-4-Gall-Bladder-adenocarcinoma-Cancer" target="_blank" action_mousedown="QuestionLinkClickthrough" id="__w2_ZhKsB6C_link"><span class="question_text"><span id="ld_ktzliu_74364"></span><span class="rendered_qtext">What are the best treatment options (Main Stream and Alternative) for Stage 4 Gall Bladder adenocarcinoma Cancer?</span></span></a></div></div></li><li class="related_question"><div id="__w2_oTqTHCR_actionable"><div id="ld_ktzliu_74355"><a class="question_link" href="/Can-exon-skipping-cure-all-mutations" target="_blank" action_mousedown="QuestionLinkClickthrough" id="__w2_nzLm7vi_link"><span class="question_text"><span id="ld_ktzliu_74365"></span><span class="rendered_qtext">Can exon skipping "cure" all mutations?</span></span></a></div></div></li><li class="related_question"><div id="__w2_YieCIln_actionable"><div id="ld_ktzliu_74356"><a class="question_link" href="/Patients/Is-it-naive-to-ask-too-many-questions-about-Lab-reports-from-a-doctor" target="_blank" action_mousedown="QuestionLinkClickthrough" id="__w2_SXldfsb_link"><span class="question_text"><span id="ld_ktzliu_74369"><span class="question_context"><span id="ld_ktzliu_74372"><span class="TopicNameSpan TopicName">Patients</span></span><span class="normal">:</span> </span></span><span class="rendered_qtext"><div class="qtext_para">Is it naive to ask too many questions about Lab reports from a doctor?</div></span></span></a></div></div></li><li class="related_question"><div id="__w2_eYVi5DQ_actionable"><div id="ld_ktzliu_74357"><a class="question_link" href="/Aging/How-do-tyrosine-kinase-inhibitors-affect-lifespan" target="_blank" action_mousedown="QuestionLinkClickthrough" id="__w2_pPbpiGd_link"><span class="question_text"><span id="ld_ktzliu_74370"><span class="question_context"><span id="ld_ktzliu_74373"><span class="TopicNameSpan TopicName">Aging</span></span><span class="normal">:</span> </span></span><span class="rendered_qtext">How do tyrosine kinase inhibitors affect lifespan?</span></span></a></div></div></li><li class="related_question"><div id="__w2_cfh1ejR_actionable"><div id="ld_ktzliu_74358"><a class="question_link" href="/Biochemistry/What-are-the-drawbacks-of-tyrosine-kinase-inhibitors" target="_blank" action_mousedown="QuestionLinkClickthrough" id="__w2_zVLbAB5_link"><span class="question_text"><span id="ld_ktzliu_74371"><span class="question_context"><span id="ld_ktzliu_74374"><span class="TopicNameSpan TopicName">Biochemistry</span></span><span class="normal">:</span> </span></span><span class="rendered_qtext">What are the drawbacks of tyrosine-kinase inhibitors?</span></span></a></div></div></li><li class="related_question"><div id="__w2_kRLuYq5_actionable"><div id="ld_ktzliu_74359"><a class="question_link" href="/How-is-PCR-used-to-detect-gene-mutation-in-the-case-of-a-suspected-cancer-patient" target="_blank" action_mousedown="QuestionLinkClickthrough" id="__w2_CPmP19I_link"><span class="question_text"><span id="ld_ktzliu_74366"></span><span class="rendered_qtext">How is PCR used to detect gene mutation in the case of a suspected cancer patient?</span></span></a></div></div></li><li class="related_question"><div id="__w2_kxY5f31_actionable"><div id="ld_ktzliu_74360"><a class="question_link" href="/Can-two-different-cancer-patients-have-the-same-gene-mutation" target="_blank" action_mousedown="QuestionLinkClickthrough" id="__w2_R5gKIKL_link"><span class="question_text"><span id="ld_ktzliu_74367"></span><span class="rendered_qtext">Can two different cancer patients have the same gene mutation?</span></span></a></div></div></li><li class="related_question"><div id="__w2_Q21rden_actionable"><div id="ld_ktzliu_74361"><a class="question_link" href="/Can-stage-4-kidney-patient-take-colace" target="_blank" action_mousedown="QuestionLinkClickthrough" id="__w2_Bbx4MbJ_link"><span class="question_text"><span id="ld_ktzliu_74368"></span><span class="rendered_qtext">Can stage 4 kidney patient take colace?</span></span></a></div></div></li></ul></div></div></div></div><div class="SimpleToggle RelatedQuestions Toggle hidden" id="__w2_RLntjJQ__expanded"></div></div></div></div></div></div></div></div></div></div></div></div><div class="clearfix" id="ld_avoovn_11997"><div class="SimpleToggle LoggedOutContentPageFeed Toggle ContentPageFeed" id="__w2_BnyXTdw__truncated"><div class="SimpleToggle LoggedOutContentPageFeed Toggle ContentPageFeed" id="__w2_BnyXTdw_wrapper"><div class="ContentWrapper top_stories_content_wrapper first_content_page_feed"><a class="title" href="/" target="_blank">Top Stories</a><span class="" id="__w2_BnyXTdw_loadingshow"><div class="Spinner" id="__w2_s54UCqM_display_area"><div class=" __w2_Spinner_Component "><div class="__q_spinner" role="progressbar" style="position: relative; width: 0px; z-index: 999;"><div style="position: absolute; top: -1px; opacity: 0.25; animation: opacity-70-25-0-12 1s linear infinite;"><div style="position: absolute; width: 6px; height: 2px; box-shadow: rgba(0, 0, 0, 0.0980392) 0px 0px 1px; transform-origin: left 50% 0px; transform: rotate(0deg) translate(5px, 0px) scale(1); border-radius: 1px; background: rgb(153, 153, 153);"></div></div><div style="position: absolute; top: -1px; opacity: 0.25; animation: opacity-70-25-1-12 1s linear infinite;"><div style="position: absolute; width: 6px; height: 2px; box-shadow: rgba(0, 0, 0, 0.0980392) 0px 0px 1px; transform-origin: left 50% 0px; transform: rotate(30deg) translate(5px, 0px) scale(1); border-radius: 1px; background: rgb(153, 153, 153);"></div></div><div style="position: absolute; top: -1px; opacity: 0.25; animation: opacity-70-25-2-12 1s linear infinite;"><div style="position: absolute; width: 6px; height: 2px; box-shadow: rgba(0, 0, 0, 0.0980392) 0px 0px 1px; transform-origin: left 50% 0px; transform: rotate(60deg) translate(5px, 0px) scale(1); border-radius: 1px; background: rgb(153, 153, 153);"></div></div><div style="position: absolute; top: -1px; opacity: 0.25; animation: opacity-70-25-3-12 1s linear infinite;"><div style="position: absolute; width: 6px; height: 2px; box-shadow: rgba(0, 0, 0, 0.0980392) 0px 0px 1px; transform-origin: left 50% 0px; transform: rotate(90deg) translate(5px, 0px) scale(1); border-radius: 1px; background: rgb(153, 153, 153);"></div></div><div style="position: absolute; top: -1px; opacity: 0.25; animation: opacity-70-25-4-12 1s linear infinite;"><div style="position: absolute; width: 6px; height: 2px; box-shadow: rgba(0, 0, 0, 0.0980392) 0px 0px 1px; transform-origin: left 50% 0px; transform: rotate(120deg) translate(5px, 0px) scale(1); border-radius: 1px; background: rgb(153, 153, 153);"></div></div><div style="position: absolute; top: -1px; opacity: 0.25; animation: opacity-70-25-5-12 1s linear infinite;"><div style="position: absolute; width: 6px; height: 2px; box-shadow: rgba(0, 0, 0, 0.0980392) 0px 0px 1px; transform-origin: left 50% 0px; transform: rotate(150deg) translate(5px, 0px) scale(1); border-radius: 1px; background: rgb(153, 153, 153);"></div></div><div style="position: absolute; top: -1px; opacity: 0.25; animation: opacity-70-25-6-12 1s linear infinite;"><div style="position: absolute; width: 6px; height: 2px; box-shadow: rgba(0, 0, 0, 0.0980392) 0px 0px 1px; transform-origin: left 50% 0px; transform: rotate(180deg) translate(5px, 0px) scale(1); border-radius: 1px; background: rgb(153, 153, 153);"></div></div><div style="position: absolute; top: -1px; opacity: 0.25; animation: opacity-70-25-7-12 1s linear infinite;"><div style="position: absolute; width: 6px; height: 2px; box-shadow: rgba(0, 0, 0, 0.0980392) 0px 0px 1px; transform-origin: left 50% 0px; transform: rotate(210deg) translate(5px, 0px) scale(1); border-radius: 1px; background: rgb(153, 153, 153);"></div></div><div style="position: absolute; top: -1px; opacity: 0.25; animation: opacity-70-25-8-12 1s linear infinite;"><div style="position: absolute; width: 6px; height: 2px; box-shadow: rgba(0, 0, 0, 0.0980392) 0px 0px 1px; transform-origin: left 50% 0px; transform: rotate(240deg) translate(5px, 0px) scale(1); border-radius: 1px; background: rgb(153, 153, 153);"></div></div><div style="position: absolute; top: -1px; opacity: 0.25; animation: opacity-70-25-9-12 1s linear infinite;"><div style="position: absolute; width: 6px; height: 2px; box-shadow: rgba(0, 0, 0, 0.0980392) 0px 0px 1px; transform-origin: left 50% 0px; transform: rotate(270deg) translate(5px, 0px) scale(1); border-radius: 1px; background: rgb(153, 153, 153);"></div></div><div style="position: absolute; top: -1px; opacity: 0.25; animation: opacity-70-25-10-12 1s linear infinite;"><div style="position: absolute; width: 6px; height: 2px; box-shadow: rgba(0, 0, 0, 0.0980392) 0px 0px 1px; transform-origin: left 50% 0px; transform: rotate(300deg) translate(5px, 0px) scale(1); border-radius: 1px; background: rgb(153, 153, 153);"></div></div><div style="position: absolute; top: -1px; opacity: 0.25; animation: opacity-70-25-11-12 1s linear infinite;"><div style="position: absolute; width: 6px; height: 2px; box-shadow: rgba(0, 0, 0, 0.0980392) 0px 0px 1px; transform-origin: left 50% 0px; transform: rotate(330deg) translate(5px, 0px) scale(1); border-radius: 1px; background: rgb(153, 153, 153);"></div></div></div></div></div></span></div></div></div><div class="SimpleToggle LoggedOutContentPageFeed Toggle ContentPageFeed hidden" id="__w2_BnyXTdw__expanded"><div class="__contentfor_loading_dots"><div class="LoadingDots regular"><div class="dot first"></div><div class="dot second"></div><div class="dot third"></div></div></div></div></div><div class="LargeFooter"><div class="footer_alphabet"><div class="alphabet_item"><a href="/sitemap">Sitemap</a></div><div class="alphabet_item"><a href="/sitemap/alphabetical_topics/0">#</a></div><span class="alphabet_item"><a href="/sitemap/alphabetical_topics/a">A</a></span><span class="alphabet_item"><a href="/sitemap/alphabetical_topics/b">B</a></span><span class="alphabet_item"><a href="/sitemap/alphabetical_topics/c">C</a></span><span class="alphabet_item"><a href="/sitemap/alphabetical_topics/d">D</a></span><span class="alphabet_item"><a href="/sitemap/alphabetical_topics/e">E</a></span><span class="alphabet_item"><a href="/sitemap/alphabetical_topics/f">F</a></span><span class="alphabet_item"><a href="/sitemap/alphabetical_topics/g">G</a></span><span class="alphabet_item"><a href="/sitemap/alphabetical_topics/h">H</a></span><span class="alphabet_item"><a href="/sitemap/alphabetical_topics/i">I</a></span><span class="alphabet_item"><a href="/sitemap/alphabetical_topics/j">J</a></span><span class="alphabet_item"><a href="/sitemap/alphabetical_topics/k">K</a></span><span class="alphabet_item"><a href="/sitemap/alphabetical_topics/l">L</a></span><span class="alphabet_item"><a href="/sitemap/alphabetical_topics/m">M</a></span><span class="alphabet_item"><a href="/sitemap/alphabetical_topics/n">N</a></span><span class="alphabet_item"><a href="/sitemap/alphabetical_topics/o">O</a></span><span class="alphabet_item"><a href="/sitemap/alphabetical_topics/p">P</a></span><span class="alphabet_item"><a href="/sitemap/alphabetical_topics/q">Q</a></span><span class="alphabet_item"><a href="/sitemap/alphabetical_topics/r">R</a></span><span class="alphabet_item"><a href="/sitemap/alphabetical_topics/s">S</a></span><span class="alphabet_item"><a href="/sitemap/alphabetical_topics/t">T</a></span><span class="alphabet_item"><a href="/sitemap/alphabetical_topics/u">U</a></span><span class="alphabet_item"><a href="/sitemap/alphabetical_topics/v">V</a></span><span class="alphabet_item"><a href="/sitemap/alphabetical_topics/w">W</a></span><span class="alphabet_item"><a href="/sitemap/alphabetical_topics/x">X</a></span><span class="alphabet_item"><a href="/sitemap/alphabetical_topics/y">Y</a></span><span class="alphabet_item"><a href="/sitemap/alphabetical_topics/z">Z</a></span></div><div class="footer_static_items"><a href="/about">About</a> - <a href="/careers">Careers</a> - <a href="/about/privacy">Privacy</a> - <a href="/about/tos">Terms</a></div></div><div id="ld_avoovn_11992"></div><div class="__live_spinner hidden" id="__w2_kFlTejy_loading"><div class="__live_spinner_indicator" id="__w2_kFlTejy_spinner"></div></div><div id="ld_avoovn_11994"></div><div class="tiny_swf"><object type="application/x-shockwave-flash" allowscriptaccess="always" data="https://qsf.is.quoracdn.net/-7cf2d1365dbaf88e.swf" width="1" height="1" id="__w2_LpsbyJc_flash" style="visibility: visible;"><param name="allowScriptAccess" value="always" /><param name="flashvars" value="domain=www.quora.com" /></object></div><img src="/_/a3836762b015b746bf113d118b0bd1da.gif?hash=03b67b74-27f3-4489-bbf4-090c11a39162" style="display: none" /><script type="text/javascript">require.whenReady("shared/main-loaded",function(){require("shared/main-loaded");
require.enqueue(function(require) {
    require('webnode2').windowId = "dep2508-658848286276270328";
});
});</script><script type="text/javascript">require.whenReady("shared/main-loaded",function(){require("shared/main-loaded");
require.enqueue(function(require) {
    require("tchannel_up").start(0, "main-w-dep2508-658848286276270328", "chan24-8888", "quora.com", "");
});
});</script><script type="text/javascript">require.whenReady("shared/main-loaded",function(){require("shared/main-loaded");
            require.enqueue(function(require) {
                require("cookies").cookie("tz", new Date().getTimezoneOffset(), {"path": "/"});
            });
            });</script><script src="https://www.google.com/recaptcha/api.js" async="" defer=""></script><script type="text/javascript">require.whenReady("shared/main-loaded",function(){require("shared/main-loaded");document.title="What does 18 bp deletion in exon 19 of EGFR gene signify in a patient of stage 4 adenocarcinoma? The exon 21 shows no mutation. Can the tyrosine kinase inhibitors be used in such a patient? - Quora";
                require.enqueue(function(require) {
                    if (window.w2_timing)
                        w2_timing.logTime('componentInitStart');
                    var W2 = require('webnode2');
            W2.addComponentMetadata({parents: {"a9T4m6z": "FnjG1fn", "oTqTHCR": "mIPNQmj", "mvwZ0gs": "Nu1UPGz", "nzLm7vi": "oTqTHCR", "bj0XT0D": "*ROOT*", "YDiLVKQ": "ZhKsB6C", "e05Cu2s": "TrNUy64", "njVqx8y": "JbE1Kms", "kXj1Flk": "dbr2CCR", "msGHAEE": "RpKMmbx", "tQ0yD03": "zVLbAB5", "pnLTeif": "RpKMmbx", "mIPNQmj": "RLntjJQ", "Bbx4MbJ": "Q21rden", "KNScVsP": "Eoi9UHN", "nvTenLj": "hzNrTQZ", "M3BEqdw": "z58XOyH", "fNmmtDg": "oshntg7", "TLtFbwM": "lXDZyoW", "CLEydCq": "MhADZYb", "L7GllkC": "LP8zMgg", "JrcpmkR": "z58XOyH", "S8Wnt3v": "L7GllkC", "WcC7BTr": "TCLjGD3", "pPbpiGd": "eYVi5DQ", "zl65tZS": "z58XOyH", "wj6xKGt": "wOt8Psp", "FUmZUrN": "Y0Eu4E5", "zUmESsG": "JJ8jy4M", "nO6DwDD": "XQaLoA1", "Fc5WwL5": "*ROOT*", "lkqhzdM": "cIoKsMy", "YZWW5ll": "qbeADnN", "LpsbyJc": "*ROOT*", "pCjaj1N": "Bbx4MbJ", "WLqOqdK": "HpaYcRU", "idJMrOX": "c8cvoxw", "MwCObfX": "ueIxUQ4", "URtoty9": "chwbATw", "XllMHlu": "BzEECs8", "zBL26sT": "e2HlV0l", "p0ZbGNa": "idJMrOX", "kMzy472": "xZFgqRx", "pOlGQJY": "R7CiuSf", "Hd19Zf5": "*ROOT*", "hRBqhVG": "wj6xKGt", "RoIvJm3": "M3BEqdw", "rzhG6vF": "fipEJ8G", "aOkuXmR": "Eoi9UHN", "M9wxiN7": "nzLm7vi", "YYDzhw8": "R5gKIKL", "SXldfsb": "YieCIln", "wh85suQ": "itUB0av", "kTDyfkX": "*ROOT*", "z58XOyH": "SxGJyCL", "vQMtavb": "pPbpiGd", "B8gErlT": "*ROOT*", "kRLuYq5": "mIPNQmj", "hBJJwuF": "bGXbcIe", "c8yaR92": "cIoKsMy", "Nch6jXT": "uH1CStN", "Vba7irz": "WVJVSO6", "KQokkDA": "*ROOT*", "DEn58CI": "z58XOyH", "yNgeMMP": "Tdt30LI", "nCDHgxU": "JrcpmkR", "SwYMrmV": "ot3UDXK", "VXSZkS6": "jnyv3re", "uXynt5A": "uH1CStN", "XQaLoA1": "k7HBltw", "EhPzKDE": "e05Cu2s", "PKu7IDT": "lXDZyoW", "Ns5SOXG": "Ut1bE1j", "p5W40D1": "vQMtavb", "MFkYdeZ": "x0tgB0l", "x2D3UKc": "idJMrOX", "HpaYcRU": "uH1CStN", "PoeIP4Z": "Eoi9UHN", "WyQHWyA": "a9T4m6z", "VqBdrA7": "LP8zMgg", "zvr4bNz": "mIPNQmj", "c0X55t7": "CIlCmdY", "HOMEQCR": "*ROOT*", "sfLnpUo": "CLEydCq", "e9zYL9E": "BarWVM3", "OWFU0eh": "tQ0yD03", "qbeADnN": "V4JBCsi", "pxJChdW": "Nu1UPGz", "gqNlpIZ": "mIPNQmj", "qmMbycf": "idJMrOX", "DgzKYMv": "a9T4m6z", "tUGqy3m": "uH1CStN", "CPmP19I": "kRLuYq5", "GYSl6Cv": "DwGqDoZ", "EozIeYc": "pnLTeif", "Mu4UFW8": "yLpjlsO", "k7HBltw": "x0tgB0l", "J6a63TJ": "Cm83j8W", "LLyadbl": "x0tgB0l", "VA5cSFB": "PoeIP4Z", "alo73QX": "t612flh", "Ggajwq4": "LLyadbl", "cIoKsMy": "I0UAPcx", "v7DXNT3": "k7HBltw", "CM9G2xR": "*ROOT*", "Q21rden": "mIPNQmj", "IBRzVti": "idJMrOX", "mpZVF2R": "yNgeMMP", "HhOQeDi": "hBJJwuF", "ueIxUQ4": "LLyadbl", "x0tgB0l": "lXDZyoW", "bAjCzxe": "tTdLROG", "WVJVSO6": "z58XOyH", "F0Z9Gir": "DwGqDoZ", "BzEECs8": "HOMEQCR", "ilajed5": "HOMEQCR", "R5gKIKL": "kxY5f31", "zArsKqF": "Nu1UPGz", "XPUQPVN": "MFNMqdj", "CIlCmdY": "S8Wnt3v", "Jbj7mEw": "*ROOT*", "taLI0RC": "BE3Co8s", "BarWVM3": "ZuqiVNM", "shPodUD": "BVsB405", "uXOd2Y7": "z58XOyH", "IOas4bp": "idJMrOX", "oY4kaDI": "CB0mH7Z", "Cm83j8W": "IMftZeq", "MOaO2zK": "*ROOT*", "SxGJyCL": "k7HBltw", "N4WaaRu": "J6a63TJ", "BL68ZMZ": "FUmZUrN", "FnjG1fn": "LLyadbl", "e2HlV0l": "dWQQYNj", "YAR0aK1": "k7HBltw", "DKmiyQc": "nvTenLj", "ot3UDXK": "SXldfsb", "M6JL5tG": "dqEKSVx", "N6PSL0Q": "e2HlV0l", "MhADZYb": "z58XOyH", "pvEIhv0": "VnxZBBD", "D7cxk13": "robneA3", "a4N7bPs": "JA3sW1v", "yLpjlsO": "wh85suQ", "m0KlbOS": "cIoKsMy", "kxY5f31": "mIPNQmj", "Bw3Emru": "lXDZyoW", "dWQQYNj": "rzhG6vF", "xrEPWa0": "Nu1UPGz", "m9JTEQm": "nRAOZUg", "s54UCqM": "BnyXTdw", "bGXbcIe": "RpKMmbx", "eYVi5DQ": "mIPNQmj", "BE3Co8s": "Vba7irz", "Eoi9UHN": "e2HlV0l", "chwbATw": "dbr2CCR", "v6PP3WT": "oY4kaDI", "KDM6ZTL": "X3iT7Uu", "vO3ihC6": "KNScVsP", "lXMNk5I": "KE0m9vE", "X3iT7Uu": "z58XOyH", "wOt8Psp": "RpKMmbx", "oshntg7": "PsWd8ei", "TBF4NiC": "HOMEQCR", "hzNrTQZ": "mIPNQmj", "YieCIln": "mIPNQmj", "xZFgqRx": "nCDHgxU", "axxxHc0": "a9T4m6z", "kFlTejy": "*ROOT*", "dbr2CCR": "cIoKsMy", "XAVbQ6Y": "x0tgB0l", "IMftZeq": "a9T4m6z", "c8cvoxw": "e2HlV0l", "sXZST77": "PoeIP4Z", "TCWaILr": "idJMrOX", "oXiLx8K": "kXj1Flk", "gqAc3O8": "IOas4bp", "Xn8bbni": "BzEECs8", "Tdt30LI": "RpKMmbx", "hQEFdz4": "tUGqy3m", "I0UAPcx": "G0A5av7", "cfh1ejR": "mIPNQmj", "BnyXTdw": "HOMEQCR", "V4JBCsi": "z58XOyH", "TrNUy64": "z58XOyH", "gJlqYFb": "ZfwmeoK", "Nu1UPGz": "x0tgB0l", "t612flh": "z58XOyH", "V7VBNiA": "xhBT5OC", "ZvZWsgb": "CIlCmdY", "tfSlVXa": "Nu1UPGz", "MFNMqdj": "zl65tZS", "PsWd8ei": "axxxHc0", "B4nZg7s": "bAjCzxe", "JbE1Kms": "alo73QX", "ZfwmeoK": "KDM6ZTL", "fipEJ8G": "LP8zMgg", "u3JNiZw": "e9zYL9E", "dqEKSVx": "EozIeYc", "L7989Wy": "k7HBltw", "nRAOZUg": "zvr4bNz", "G0A5av7": "VqBdrA7", "jnyv3re": "DEn58CI", "CB0mH7Z": "dbr2CCR", "BVsB405": "z58XOyH", "RpKMmbx": "V7VBNiA", "zmDRHWU": "kXj1Flk", "uH1CStN": "c8yaR92", "R9PHQOM": "*ROOT*", "uXvrV1E": "BL68ZMZ", "t82WAGh": "XllMHlu", "HI3WU15": "HOMEQCR", "RLntjJQ": "XAVbQ6Y", "robneA3": "z58XOyH", "lWHl94S": "Nu1UPGz", "bVz5PGF": "uH1CStN", "lXDZyoW": "HOMEQCR", "KE0m9vE": "aOkuXmR", "Ay0XYwu": "MwCObfX", "Y0Eu4E5": "z58XOyH", "lkJ5AQZ": "WcC7BTr", "JJ8jy4M": "p0ZbGNa", "VnxZBBD": "msGHAEE", "YfE0GoW": "hQEFdz4", "aayysJ0": "v7DXNT3", "DwGqDoZ": "KNScVsP", "xhBT5OC": "LP8zMgg", "QwEYFYu": "LP8zMgg", "lMe1s97": "lXDZyoW", "itUB0av": "a9T4m6z", "tTdLROG": "WyQHWyA", "hBdZK7D": "RoIvJm3", "iEciVtM": "GYSl6Cv", "ZuqiVNM": "z58XOyH", "Tkqh9GW": "uH1CStN", "ENGc9F8": "DgzKYMv", "TCLjGD3": "uXOd2Y7", "JA3sW1v": "shPodUD", "A2zNGKv": "CPmP19I", "R7CiuSf": "ENGc9F8", "zVLbAB5": "cfh1ejR", "ZhKsB6C": "gqNlpIZ", "LP8zMgg": "YAR0aK1", "Ut1bE1j": "D7cxk13"}, children: {"HOMEQCR": {"content": "lXDZyoW"}, "LP8zMgg": {"more_button": "QwEYFYu"}, "BzEECs8": {"lookup_bar": "XllMHlu"}}, knowsAbout: {"LLyadbl": {"question_main_editor": "."}, "YfE0GoW": {"hover_menu": "."}, "XllMHlu": {"wizard": "wizard", "add_question": "add_question", "results": "results", "selector": "."}, "cIoKsMy": {"answer": "."}, "RLntjJQ": {"toggled": "toggled"}, "e2HlV0l": {"answer": "."}, "Cm83j8W": {"topic_name_link": "."}, "sXZST77": {"hover_menu": "."}, "CB0mH7Z": {"hover_menu": "."}, "aOkuXmR": {"hover_menu": "."}, "tTdLROG": {"topic_name_link": "."}, "oXiLx8K": {"hover_menu": "."}, "HOMEQCR": {"content": "content", "layout": "."}, "x0tgB0l": {"home_logged_out": ".", "question_topics": "question_topics"}, "wh85suQ": {"topic_name_link": "."}, "PsWd8ei": {"topic_name_link": "."}, "F0Z9Gir": {"hover_menu": "."}, "ENGc9F8": {"topic_name_link": "."}, "pxJChdW": {"toggled": "toggled"}, "zUmESsG": {"hover_menu": "."}, "GYSl6Cv": {"topic_name_link": "."}, "LP8zMgg": {"more_button": "more_button", "html_nav": "html_nav"}}, groups: {"__w2_XllMHlu_interaction": ["__w2_XllMHlu_input"]}, domids: {"a9T4m6z": "ld_qiqlfz_67807", "mvwZ0gs": "ld_ciryxk_76672", "nzLm7vi": "ld_ktzliu_74355", "YDiLVKQ": "ld_ktzliu_74364", "e05Cu2s": "ld_cxmgem_64407", "njVqx8y": "ld_cxmgem_64442", "tQ0yD03": "ld_ktzliu_74371", "uXvrV1E": "ld_cxmgem_64436", "Bbx4MbJ": "ld_ktzliu_74361", "KNScVsP": "ld_xmhwjp_70445", "nvTenLj": "ld_ktzliu_74353", "CLEydCq": "ld_cxmgem_64411", "L7GllkC": "ld_jzckxs_73204", "S8Wnt3v": "ld_dnjbfs_73537", "WcC7BTr": "ld_cxmgem_64426", "pPbpiGd": "ld_ktzliu_74357", "wj6xKGt": "ld_klfoee_70996", "FUmZUrN": "ld_cxmgem_64406", "nO6DwDD": "ld_ihqyxl_68014", "lkqhzdM": "ld_nnggfb_71095", "idJMrOX": "ld_jtrrlm_70066", "MwCObfX": "ld_wmdaha_74175", "zBL26sT": "ld_jjjtlr_70611", "Ut1bE1j": "ld_cxmgem_64430", "kXj1Flk": "ld_nuthnv_74220", "RoIvJm3": "ld_cxmgem_64413", "rzhG6vF": "ld_hobndj_73571", "aOkuXmR": "ld_xmhwjp_70443", "M9wxiN7": "ld_ktzliu_74365", "YYDzhw8": "ld_ktzliu_74367", "SXldfsb": "ld_ktzliu_74356", "wh85suQ": "ld_xphvvh_71012", "vQMtavb": "ld_ktzliu_74370", "pxJChdW": "ld_ciryxk_76674", "VXSZkS6": "ld_cxmgem_64422", "Vba7irz": "ld_cxmgem_64412", "KQokkDA": "ld_avoovn_11992", "yNgeMMP": "ld_klfoee_70994", "nCDHgxU": "ld_cxmgem_64415", "SwYMrmV": "ld_ktzliu_74372", "XQaLoA1": "ld_ihqyxl_68011", "EhPzKDE": "ld_cxmgem_64420", "Ns5SOXG": "ld_cxmgem_64439", "p5W40D1": "ld_ktzliu_74373", "HpaYcRU": "ld_ciryxk_76678", "Nch6jXT": "ld_ciryxk_76679", "PoeIP4Z": "ld_xmhwjp_70444", "hBJJwuF": "ld_klfoee_70995", "VqBdrA7": "ld_jzckxs_73203", "c0X55t7": "ld_iyimpg_68946", "sfLnpUo": "ld_cxmgem_64423", "e9zYL9E": "ld_cxmgem_64432", "OWFU0eh": "ld_ktzliu_74374", "qbeADnN": "ld_cxmgem_64416", "DgzKYMv": "ld_xphvvh_71006", "V7VBNiA": "ld_odibui_70435", "CPmP19I": "ld_ktzliu_74359", "EozIeYc": "ld_klfoee_70997", "k7HBltw": "ld_ciryxk_76670", "J6a63TJ": "ld_xphvvh_71014", "LLyadbl": "ld_ciryxk_76671", "alo73QX": "ld_cxmgem_64418", "Ggajwq4": "ld_wmdaha_74174", "cIoKsMy": "ld_ruweyh_71467", "v7DXNT3": "ld_ihqyxl_68010", "Cm83j8W": "ld_xphvvh_71009", "chwbATw": "ld_nuthnv_74221", "mpZVF2R": "ld_klfoee_70999", "HhOQeDi": "ld_klfoee_71000", "ueIxUQ4": "ld_wmdaha_74173", "x0tgB0l": "ld_shnakz_78717", "bAjCzxe": "ld_xphvvh_71018", "BzEECs8": "ld_avoovn_11995", "R5gKIKL": "ld_ktzliu_74360", "m0KlbOS": "ld_nnggfb_71094", "QwEYFYu": "ld_jzckxs_73205", "CIlCmdY": "ld_iyimpg_68945", "I0UAPcx": "ld_ruweyh_71466", "Jbj7mEw": "ld_avoovn_11994", "BarWVM3": "ld_cxmgem_64417", "shPodUD": "ld_cxmgem_64410", "IOas4bp": "ld_shnakz_78719", "YZWW5ll": "ld_cxmgem_64425", "pCjaj1N": "ld_ktzliu_74368", "SxGJyCL": "ld_ihqyxl_68013", "uH1CStN": "ld_nxqroq_71817", "BL68ZMZ": "ld_cxmgem_64427", "FnjG1fn": "ld_wmdaha_74172", "e2HlV0l": "ld_udhbbd_68334", "DKmiyQc": "ld_ktzliu_74363", "ot3UDXK": "ld_ktzliu_74369", "M6JL5tG": "ld_klfoee_71003", "N6PSL0Q": "ld_jjjtlr_70612", "pvEIhv0": "ld_klfoee_70998", "D7cxk13": "ld_cxmgem_64414", "a4N7bPs": "ld_cxmgem_64437", "yLpjlsO": "ld_xphvvh_71017", "hRBqhVG": "ld_klfoee_71001", "xrEPWa0": "ld_ciryxk_76675", "m9JTEQm": "ld_ktzliu_74362", "KDM6ZTL": "ld_cxmgem_64419", "BE3Co8s": "ld_cxmgem_64429", "Eoi9UHN": "ld_jjjtlr_70610", "taLI0RC": "ld_cxmgem_64438", "lXMNk5I": "ld_xmhwjp_70446", "oshntg7": "ld_xphvvh_71015", "VnxZBBD": "ld_klfoee_70993", "itUB0av": "ld_xphvvh_71007", "xZFgqRx": "ld_cxmgem_64431", "axxxHc0": "ld_xphvvh_71005", "dbr2CCR": "ld_nnggfb_71093", "u3JNiZw": "ld_cxmgem_64441", "c8cvoxw": "ld_jjjtlr_70613", "TCWaILr": "ld_shnakz_78720", "c8yaR92": "ld_nnggfb_71096", "v6PP3WT": "ld_nuthnv_74222", "BnyXTdw": "ld_avoovn_11997", "gJlqYFb": "ld_cxmgem_64443", "MFNMqdj": "ld_cxmgem_64408", "PsWd8ei": "ld_xphvvh_71010", "JbE1Kms": "ld_cxmgem_64433", "ZfwmeoK": "ld_cxmgem_64434", "IMftZeq": "ld_xphvvh_71004", "dqEKSVx": "ld_klfoee_71002", "L7989Wy": "ld_ihqyxl_68012", "nRAOZUg": "ld_ktzliu_74352", "G0A5av7": "ld_izkhvb_69986", "CB0mH7Z": "ld_nuthnv_74219", "WyQHWyA": "ld_xphvvh_71008", "R9PHQOM": "ld_avoovn_11993", "RLntjJQ": "ld_ciryxk_76677", "fipEJ8G": "ld_jzckxs_73201", "lWHl94S": "ld_ciryxk_76673", "lXDZyoW": "ld_avoovn_11996", "Ay0XYwu": "ld_wmdaha_74176", "lkJ5AQZ": "ld_cxmgem_64435", "zArsKqF": "ld_ciryxk_76676", "aayysJ0": "ld_ihqyxl_68016", "xhBT5OC": "ld_jzckxs_73202", "XPUQPVN": "ld_cxmgem_64421", "dWQQYNj": "ld_udhbbd_68333", "tTdLROG": "ld_xphvvh_71013", "hBdZK7D": "ld_cxmgem_64424", "iEciVtM": "ld_ihqyxl_68017", "jnyv3re": "ld_cxmgem_64409", "ENGc9F8": "ld_xphvvh_71011", "TCLjGD3": "ld_cxmgem_64405", "JA3sW1v": "ld_cxmgem_64428", "A2zNGKv": "ld_ktzliu_74366", "R7CiuSf": "ld_xphvvh_71016", "zVLbAB5": "ld_ktzliu_74358", "ZhKsB6C": "ld_ktzliu_74354", "LP8zMgg": "ld_ihqyxl_68015", "kMzy472": "ld_cxmgem_64440"}, hmacs: {"a9T4m6z": "UylPNrkrE2pj93", "oTqTHCR": "zdhW+uWlLCvjDX", "mvwZ0gs": "1IspgN5S4Iu5i3", "nzLm7vi": "Q5DU4FheKYIIfH", "bj0XT0D": "PZehp13DRwulzr", "YDiLVKQ": "KVbeJdpzIlHZKH", "e05Cu2s": "Q5DU4FheKYIIfH", "njVqx8y": "aNlloNV91jVqD7", "kXj1Flk": "n5GBwGV9BI0dUs", "msGHAEE": "zdhW+uWlLCvjDX", "tQ0yD03": "KVbeJdpzIlHZKH", "pnLTeif": "zdhW+uWlLCvjDX", "mIPNQmj": "Sj/25PzI0SUovs", "Bbx4MbJ": "Q5DU4FheKYIIfH", "KNScVsP": "BlNCppFmOdazkW", "nvTenLj": "Q5DU4FheKYIIfH", "M3BEqdw": "zdhW+uWlLCvjDX", "fNmmtDg": "qwSCqDY1h0l1To", "TLtFbwM": "YHfNweTms8ZWw8", "CLEydCq": "Q5DU4FheKYIIfH", "L7GllkC": "VTNM8FOisQKRkl", "JrcpmkR": "zdhW+uWlLCvjDX", "S8Wnt3v": "3Mcr12/DelJ5/d", "WcC7BTr": "KVbeJdpzIlHZKH", "pPbpiGd": "Q5DU4FheKYIIfH", "zl65tZS": "zdhW+uWlLCvjDX", "wj6xKGt": "Q5DU4FheKYIIfH", "FUmZUrN": "Q5DU4FheKYIIfH", "zUmESsG": "udZeaNz4nsP+Df", "nO6DwDD": "ZQBHmYF8pDytsu", "Fc5WwL5": "2O1ftyp2jLiIaD", "lkqhzdM": "rru/xmQaCoCVF/", "YZWW5ll": "KVbeJdpzIlHZKH", "LpsbyJc": "TKP67vMcwwrO3l", "pCjaj1N": "KVbeJdpzIlHZKH", "WLqOqdK": "5pDWD/q+wbL9s8", "idJMrOX": "PWBNuzUvleM+Ne", "MwCObfX": "AyS5v4JhQVEFah", "URtoty9": "P9Xc5/3E48D9HD", "XllMHlu": "af2epjWO7ZY1nI", "zBL26sT": "Y+AdTuthrlh2GY", "p0ZbGNa": "FC/jHnx/yzEkpN", "kMzy472": "aNlloNV91jVqD7", "pOlGQJY": "qwSCqDY1h0l1To", "Hd19Zf5": "4R3MtyRZUPRtRl", "hRBqhVG": "KVbeJdpzIlHZKH", "RoIvJm3": "Q5DU4FheKYIIfH", "rzhG6vF": "3Mcr12/DelJ5/d", "aOkuXmR": "1sfvqiW42BPR+M", "M9wxiN7": "KVbeJdpzIlHZKH", "YYDzhw8": "KVbeJdpzIlHZKH", "SXldfsb": "Q5DU4FheKYIIfH", "wh85suQ": "FFCe9FZXgmZzvm", "kTDyfkX": "8RVxElLKc7Cyo5", "z58XOyH": "Sj/25PzI0SUovs", "vQMtavb": "KVbeJdpzIlHZKH", "B8gErlT": "wzXjEjB7bkuwCN", "kRLuYq5": "zdhW+uWlLCvjDX", "hBJJwuF": "Q5DU4FheKYIIfH", "c8yaR92": "dh/F4KolQHPMP7", "Nch6jXT": "JTvtSXULcq04w6", "Vba7irz": "Q5DU4FheKYIIfH", "KQokkDA": "H4N6YL2RRfUEoi", "DEn58CI": "zdhW+uWlLCvjDX", "yNgeMMP": "Q5DU4FheKYIIfH", "nCDHgxU": "Q5DU4FheKYIIfH", "SwYMrmV": "aNlloNV91jVqD7", "VXSZkS6": "KVbeJdpzIlHZKH", "uXynt5A": "v/sbdiAGeWDv0k", "XQaLoA1": "M7472vScnT6D4K", "EhPzKDE": "KVbeJdpzIlHZKH", "PKu7IDT": "S4wcGVzUxxHge1", "Ns5SOXG": "aNlloNV91jVqD7", "p5W40D1": "aNlloNV91jVqD7", "MFkYdeZ": "nuxb4Hsod+K+Re", "x2D3UKc": "v/sbdiAGeWDv0k", "HpaYcRU": "/yfYu+Da5pGDIZ", "PoeIP4Z": "n5GBwGV9BI0dUs", "WyQHWyA": "mBvLJJlhS9t86l", "VqBdrA7": "VTNM8FOisQKRkl", "zvr4bNz": "zdhW+uWlLCvjDX", "c0X55t7": "haSoja/kiZ2YhX", "HOMEQCR": "K0N05JGUz/jylI", "sfLnpUo": "KVbeJdpzIlHZKH", "e9zYL9E": "KVbeJdpzIlHZKH", "OWFU0eh": "aNlloNV91jVqD7", "qbeADnN": "Q5DU4FheKYIIfH", "pxJChdW": "mN5MUSjCFMzpuZ", "gqNlpIZ": "zdhW+uWlLCvjDX", "qmMbycf": "7NpLYGj4IRSU86", "DgzKYMv": "mBvLJJlhS9t86l", "tUGqy3m": "FC/jHnx/yzEkpN", "CPmP19I": "Q5DU4FheKYIIfH", "GYSl6Cv": "FFCe9FZXgmZzvm", "EozIeYc": "Q5DU4FheKYIIfH", "Mu4UFW8": "qwSCqDY1h0l1To", "k7HBltw": "uN8WDh5B2aF949", "J6a63TJ": "aNlloNV91jVqD7", "LLyadbl": "quiuYiRGrgNQL1", "VA5cSFB": "PvtYvo2lFFrcbt", "alo73QX": "Q5DU4FheKYIIfH", "Ggajwq4": "NEel8/G7TMh4Zo", "cIoKsMy": "a414QTweCXacqn", "v7DXNT3": "BxheriYYELjLOo", "CM9G2xR": "9JblKMaWTbc61h", "Q21rden": "zdhW+uWlLCvjDX", "IBRzVti": "JZRCvX5I8T5IGk", "mpZVF2R": "KVbeJdpzIlHZKH", "HhOQeDi": "KVbeJdpzIlHZKH", "ueIxUQ4": "NfaiNgy9tWJiQF", "x0tgB0l": "0cgS9AjvYYU7T/", "bAjCzxe": "aNlloNV91jVqD7", "WVJVSO6": "zdhW+uWlLCvjDX", "F0Z9Gir": "9gWEOTo3Gdv8LA", "BzEECs8": "aD0i31XLd8mks2", "ilajed5": "DAalTWsvfBzxrO", "R5gKIKL": "Q5DU4FheKYIIfH", "zArsKqF": "Gvm2FXrbJ2J2+S", "XPUQPVN": "KVbeJdpzIlHZKH", "CIlCmdY": "QmptCxbbZG7bDy", "Jbj7mEw": "ze5Lm7THgFwGFu", "taLI0RC": "aNlloNV91jVqD7", "BarWVM3": "Q5DU4FheKYIIfH", "shPodUD": "Q5DU4FheKYIIfH", "uXOd2Y7": "zdhW+uWlLCvjDX", "IOas4bp": "/yfYu+Da5pGDIZ", "oY4kaDI": "ZVyghKF0FfOSEk", "Cm83j8W": "FFCe9FZXgmZzvm", "MOaO2zK": "FRM7bzTCqvlbwq", "SxGJyCL": "ate+JjecirOloA", "N4WaaRu": "qwSCqDY1h0l1To", "BL68ZMZ": "KVbeJdpzIlHZKH", "FnjG1fn": "QQM5uOUQs8WhsR", "e2HlV0l": "a414QTweCXacqn", "YAR0aK1": "JmnHIw7fbKYB10", "DKmiyQc": "KVbeJdpzIlHZKH", "ot3UDXK": "KVbeJdpzIlHZKH", "M6JL5tG": "aNlloNV91jVqD7", "N6PSL0Q": "rru/xmQaCoCVF/", "MhADZYb": "zdhW+uWlLCvjDX", "pvEIhv0": "KVbeJdpzIlHZKH", "D7cxk13": "Q5DU4FheKYIIfH", "a4N7bPs": "aNlloNV91jVqD7", "yLpjlsO": "aNlloNV91jVqD7", "m0KlbOS": "Y+AdTuthrlh2GY", "kxY5f31": "zdhW+uWlLCvjDX", "Bw3Emru": "fTqTKBA8YOwpQv", "dWQQYNj": "QmptCxbbZG7bDy", "xrEPWa0": "O8JIlcsa+sfQrF", "m9JTEQm": "KVbeJdpzIlHZKH", "s54UCqM": "XS3DjnN8blc3Qc", "bGXbcIe": "zdhW+uWlLCvjDX", "eYVi5DQ": "zdhW+uWlLCvjDX", "BE3Co8s": "KVbeJdpzIlHZKH", "Eoi9UHN": "W1gpVmqxArXyt7", "chwbATw": "BlNCppFmOdazkW", "v6PP3WT": "vHS0WoH5SmwYmQ", "KDM6ZTL": "Q5DU4FheKYIIfH", "vO3ihC6": "P9Xc5/3E48D9HD", "lXMNk5I": "vHS0WoH5SmwYmQ", "X3iT7Uu": "zdhW+uWlLCvjDX", "wOt8Psp": "zdhW+uWlLCvjDX", "oshntg7": "aNlloNV91jVqD7", "TBF4NiC": "B9kKH30vAkbmKk", "hzNrTQZ": "zdhW+uWlLCvjDX", "YieCIln": "zdhW+uWlLCvjDX", "xZFgqRx": "KVbeJdpzIlHZKH", "axxxHc0": "mBvLJJlhS9t86l", "kFlTejy": "tANVsiE+cxkDRj", "dbr2CCR": "W1gpVmqxArXyt7", "XAVbQ6Y": "fcOSlj8cZ52rRX", "IMftZeq": "mBvLJJlhS9t86l", "c8cvoxw": "dh/F4KolQHPMP7", "sXZST77": "udZeaNz4nsP+Df", "TCWaILr": "JTvtSXULcq04w6", "oXiLx8K": "udZeaNz4nsP+Df", "gqAc3O8": "5pDWD/q+wbL9s8", "Xn8bbni": "39vjVsep3JCVgD", "Tdt30LI": "zdhW+uWlLCvjDX", "hQEFdz4": "wK/q8WFANgDj5C", "I0UAPcx": "QmptCxbbZG7bDy", "cfh1ejR": "zdhW+uWlLCvjDX", "BnyXTdw": "81MJjYJpCPN2tR", "V4JBCsi": "zdhW+uWlLCvjDX", "TrNUy64": "zdhW+uWlLCvjDX", "gJlqYFb": "aNlloNV91jVqD7", "Nu1UPGz": "GfjbhFwt2Pto53", "t612flh": "zdhW+uWlLCvjDX", "V7VBNiA": "ate+JjecirOloA", "ZvZWsgb": "nnYzKJpMTjNZ9Q", "tfSlVXa": "pZ0LEKydcXty3N", "MFNMqdj": "Q5DU4FheKYIIfH", "PsWd8ei": "FFCe9FZXgmZzvm", "B4nZg7s": "qwSCqDY1h0l1To", "JbE1Kms": "KVbeJdpzIlHZKH", "ZfwmeoK": "KVbeJdpzIlHZKH", "fipEJ8G": "VTNM8FOisQKRkl", "u3JNiZw": "aNlloNV91jVqD7", "dqEKSVx": "KVbeJdpzIlHZKH", "L7989Wy": "MeeuXNsnyDnwF3", "nRAOZUg": "Q5DU4FheKYIIfH", "G0A5av7": "3Mcr12/DelJ5/d", "jnyv3re": "Q5DU4FheKYIIfH", "CB0mH7Z": "1sfvqiW42BPR+M", "BVsB405": "zdhW+uWlLCvjDX", "RpKMmbx": "Sj/25PzI0SUovs", "zmDRHWU": "PvtYvo2lFFrcbt", "uH1CStN": "PWBNuzUvleM+Ne", "R9PHQOM": "1on7AgBqko/PdP", "uXvrV1E": "aNlloNV91jVqD7", "t82WAGh": "ymWNAWNIMdOKzz", "HI3WU15": "yIhehupLwXy2ZT", "RLntjJQ": "68m7oEAL3itPPl", "robneA3": "zdhW+uWlLCvjDX", "lWHl94S": "umZv7Cxmby0TwH", "bVz5PGF": "JZRCvX5I8T5IGk", "lXDZyoW": "EvauR91jUnaDqk", "KE0m9vE": "ZVyghKF0FfOSEk", "Ay0XYwu": "5Tbv/m6gyOKxLd", "Y0Eu4E5": "zdhW+uWlLCvjDX", "lkJ5AQZ": "aNlloNV91jVqD7", "JJ8jy4M": "wK/q8WFANgDj5C", "VnxZBBD": "Q5DU4FheKYIIfH", "YfE0GoW": "udZeaNz4nsP+Df", "aayysJ0": "/NI/pgoUJ0Qv3w", "DwGqDoZ": "jJN4S6XIM5hDOQ", "xhBT5OC": "vU5ERypKnQ7qfr", "QwEYFYu": "/TW7WZFZNft72w", "lMe1s97": "dZUKqgrmjfibWg", "itUB0av": "mBvLJJlhS9t86l", "tTdLROG": "FFCe9FZXgmZzvm", "hBdZK7D": "KVbeJdpzIlHZKH", "iEciVtM": "aNlloNV91jVqD7", "ZuqiVNM": "zdhW+uWlLCvjDX", "Tkqh9GW": "7NpLYGj4IRSU86", "ENGc9F8": "FFCe9FZXgmZzvm", "TCLjGD3": "Q5DU4FheKYIIfH", "JA3sW1v": "KVbeJdpzIlHZKH", "A2zNGKv": "KVbeJdpzIlHZKH", "R7CiuSf": "aNlloNV91jVqD7", "zVLbAB5": "Q5DU4FheKYIIfH", "ZhKsB6C": "Q5DU4FheKYIIfH", "LP8zMgg": "2S24bo9orExmnI", "Ut1bE1j": "KVbeJdpzIlHZKH"}});
var newComponent = W2.newComponent;
var _components = [new(require("w2.interaction").InteractionModeBanner)("Hd19Zf5","",{},{}),
new(require("w2.livenode").ErrorBanner)("Fc5WwL5","",{"default_text": "Your request was not completed."},{}),
new(require("app/view/components").JSTest)("ilajed5","",{},{}),
new(require("app/view/site_header/logged_out").LoggedOutSiteHeader)("BzEECs8","",{"qid": 4785265, "vote_source": "question"},{}),
new(require('app/view/question/lookup_bar').LookupBarSelector)("XllMHlu","lookup_bar",{"interstitials": {"answer": ["Ask and answer a question!", "Write about what you know by asking the question first."], "bad": ["Is your question complete?", "Make sure to fill out a complete sentence that's in the form of a question."], "good": ["You're almost there!", "Make sure to double check your phrasing before you press submit."], "button": ["Ask your question here!", "Write your question as a complete sentence then press submit."], "ask_question": ["What is your question?", "Ask a question and get answers from people with unique insights."]}, "max_concurrent_requests": 3, "length_limit": null, "opening_question_punctuation": "", "shouldSendJsData": false, "hasResults": false, "selector_id": 36166498, "max_cache_size": 50, "hide_counter_on_load": false, "should_go_to_search_on_enter": false, "is_textarea": false, "logged_in": null, "allowNoSelection": true, "query": "", "queryTypingDelay": 0, "keepFilters": "", "closing_question_punctuation": "?", "should_autofocus": true},{}),
new(require("app/view/signup/conversion_logging").ConversionLogging)("Xn8bbni","",{},{}),
new(require("app/view/home").ContentPageFeed)("BnyXTdw","",{"switch_hide": "@_truncated", "key_combination": null, "switch_show": "@_expanded", "log_switch_time": false, "switch_on": ["load"], "loading_hide": "@loadinghide", "fetch_on": ["load"], "fetch_into": "@_expanded", "loading_show": "@loadingshow", "serialized_args": "000100009cd8f4391ff7b8d3ac6144309a3a752b85197d6e7011a4030826a84408a5eee30bb83353b50678ed58fbe955e0118468f566bcbb7639da51e610bef354c387aacc2d104fd220d7d85d8154fcf474bbbb01f4e016a182cc8ef9ba3be1b366df75e70c28ebcec8c3b4697e030d183db642"},{}),
new(require("view/spinner").Spinner)("s54UCqM","",{},{}),
new(require('login').LoginSignal)("KQokkDA","",{"uid": null},{}),
new(require('login').LiveLogin)("kTDyfkX","",{},{}),
new(require("view/captcha").Captcha)("B8gErlT","",{},{}),
new(require("view/reauth").ReauthWrapper)("CM9G2xR","",{},{}),
new(require("w2.livenode").LiveSpinner)("kFlTejy","",{},{}),
new(require('app/view/signup/google_').GoogleAutoLogin)("Jbj7mEw","",{"viewer": null, "scopes": ["email", "profile"]},{}),
new(require('app/view/mathjax').MathJaxLoader)("MOaO2zK","",{},{}),
new(require("flash").FlashClient)("LpsbyJc","",{"cp": "m", "swf_url": "https://qsf.is.quoracdn.net/-7cf2d1365dbaf88e.swf", "fc": "-IhGzoLK5TvrNzee2ySa8w==", "so": "main-client-1", "flash_vars": {"domain": "www.quora.com"}},{}),
new(require("view/pmsg").PMsgContainer)("TLtFbwM","",{},{}),
new(require("app/view/layout").QTextImageEnlarger)("PKu7IDT","",{},{}),
new(require("app/view/layout").QTextEmbedEnlarger)("Bw3Emru","",{},{}),
new(require("app/view/layout").QTextGIFPlayer)("lMe1s97","",{},{}),
new(require("app/view/question").QuestionMain)("x0tgB0l","",{"record_impression": true},{}),
new(require('login').LoginPageLoginListener)("MFkYdeZ","",{"next": "https://www.quora.com/What-does-18-bp-deletion-in-exon-19-of-EGFR-gene-signify-in-a-patient-of-stage-4-adenocarcinoma-The-exon-21-shows-no-mutation-Can-the-tyrosine-kinase-inhibitors-be-used-in-such-a-patient"},{}),
new(require("app/view/question").QuestionArea)("LLyadbl","",{"qid": 4785265},{}),
new(require("app/view/question").AnswerListDiv)("YAR0aK1","",{},{}),
new(require("unified_view/toggle").ToggleBase)("RLntjJQ","",{"switch_hide": "@_truncated", "key_combination": null, "switch_show": "@_expanded", "log_switch_time": false, "switch_on": ["click", "@more"], "loading_hide": "@loadinghide", "fetch_on": ["click", "@more"], "fetch_into": "@_expanded", "loading_show": "@loadingshow", "serialized_args": "0001000073630351051862aab004310b3e684cd75a3f89d6cb14d312a137fe32ee4be8c468e36a8b7d36c205c68ec6c4e08cb6dee51ad80cad1a8e8ad2e1e597b6e011c87530f86adfc89dcb510e199c58d2ce2d5df9a9b8e1ed69a1ebf3b56038e860f9800327f6fd61f86b262bbc1431794c60308b47afdc1f2a2f4872aa6d479b25b07a3c66682feeae3c4f8f761e2ea938a3f2e133a203c4b25f58236c1b0793e8e36a0e58b59e3ff05f3101706a076b8d81e5e3dc3763d31c974b5400009f32abd30d881a78042c30daa1575b59b1a1ac843ef83c90b8b6d14cf92411a50d4f6d05b2efbe2dc980b62fa9fdf1cd51f519fe4a8482c10dfc63836b4e999ccda09f0c1abb76171fcba13ce68afb575f2e0855e7972fc3ebab7a8205079d066b5595f9eb94f704da7fd0afe4bb490c89d08c25"},{}),
new(require("app/view/question").RelatedQuestionsList)("mIPNQmj","",{},{}),
new(require("app/view/question").RelatedQuestionLink)("zvr4bNz","",{"impression_target": {"hash": "related_questions|4143207|1009161341", "type": 21}},{}),
new(require("app/view/question").QuestionLink)("nRAOZUg","",{},{}),
new(require("app/view/question").RelatedQuestionLink)("hzNrTQZ","",{"impression_target": {"hash": "related_questions|2400357|1009161341", "type": 21}},{}),
new(require("app/view/question").QuestionLink)("nvTenLj","",{},{}),
new(require("app/view/question").RelatedQuestionLink)("gqNlpIZ","",{"impression_target": {"hash": "related_questions|2228847|1009161341", "type": 21}},{}),
new(require("app/view/question").QuestionLink)("ZhKsB6C","",{},{}),
new(require("app/view/question").RelatedQuestionLink)("oTqTHCR","",{"impression_target": {"hash": "related_questions|5563903|1009161341", "type": 21}},{}),
new(require("app/view/question").QuestionLink)("nzLm7vi","",{},{}),
new(require("app/view/question").RelatedQuestionLink)("YieCIln","",{"impression_target": {"hash": "related_questions|854479|1009161341", "type": 21}},{}),
new(require("app/view/question").QuestionLink)("SXldfsb","",{},{}),
new(require("app/view/question").RelatedQuestionLink)("eYVi5DQ","",{"impression_target": {"hash": "related_questions|2828564|1009161341", "type": 21}},{}),
new(require("app/view/question").QuestionLink)("pPbpiGd","",{},{}),
new(require("app/view/question").RelatedQuestionLink)("cfh1ejR","",{"impression_target": {"hash": "related_questions|2828563|1009161341", "type": 21}},{}),
new(require("app/view/question").QuestionLink)("zVLbAB5","",{},{}),
new(require("app/view/question").RelatedQuestionLink)("kRLuYq5","",{"impression_target": {"hash": "related_questions|3670867|1009161341", "type": 21}},{}),
new(require("app/view/question").QuestionLink)("CPmP19I","",{},{}),
new(require("app/view/question").RelatedQuestionLink)("kxY5f31","",{"impression_target": {"hash": "related_questions|4536998|1009161341", "type": 21}},{}),
new(require("app/view/question").QuestionLink)("R5gKIKL","",{},{}),
new(require("app/view/question").RelatedQuestionLink)("Q21rden","",{"impression_target": {"hash": "related_questions|6253318|1009161341", "type": 21}},{}),
new(require("app/view/question").QuestionLink)("Bbx4MbJ","",{},{}),
new(require("app/view/topic/topic_list").QuestionTopicHorizontalList)("FnjG1fn","",{"qid": 4785265},{}),
new(require("view/paged_list").PagedList)("LP8zMgg","",{"retarget_links": true, "buffer_count": 6, "fixed_size_paged_list": false, "capture_global_keyevents": true, "should_prefetch_feed": false, "initial_count": 6, "has_more": false, "auto_paged": true, "object_id": 4785265, "crawler": false},{}),
new(require("view/paged_list").PagedListMoreButton)("QwEYFYu","more_button",{"auto_click_period": 6000},{}),
new(require("app/view/question").RelatedQuestionsList)("z58XOyH","",{},{}),
new(require("app/view/question").RelatedQuestionLink)("uXOd2Y7","",{"impression_target": {"hash": "related_questions|2828564|1009161341", "type": 21}},{}),
new(require("app/view/question").QuestionLink)("TCLjGD3","",{},{}),
new(require("app/view/question").RelatedQuestionLink)("Y0Eu4E5","",{"impression_target": {"hash": "related_questions|2828563|1009161341", "type": 21}},{}),
new(require("app/view/question").QuestionLink)("FUmZUrN","",{},{}),
new(require("app/view/question").RelatedQuestionLink)("TrNUy64","",{"impression_target": {"hash": "related_questions|3670867|1009161341", "type": 21}},{}),
new(require("app/view/question").QuestionLink)("e05Cu2s","",{},{}),
new(require("app/view/question").RelatedQuestionLink)("zl65tZS","",{"impression_target": {"hash": "related_questions|4536998|1009161341", "type": 21}},{}),
new(require("app/view/question").QuestionLink)("MFNMqdj","",{},{}),
new(require("app/view/question").RelatedQuestionLink)("DEn58CI","",{"impression_target": {"hash": "related_questions|6253318|1009161341", "type": 21}},{}),
new(require("app/view/question").QuestionLink)("jnyv3re","",{},{}),
new(require("app/view/question").RelatedQuestionLink)("BVsB405","",{"impression_target": {"hash": "related_questions|1367682|1009161341", "type": 21}},{}),
new(require("app/view/question").QuestionLink)("shPodUD","",{},{}),
new(require("app/view/question").RelatedQuestionLink)("MhADZYb","",{"impression_target": {"hash": "related_questions|913904|1009161341", "type": 21}},{}),
new(require("app/view/question").QuestionLink)("CLEydCq","",{},{}),
new(require("app/view/question").RelatedQuestionLink)("WVJVSO6","",{"impression_target": {"hash": "related_questions|2828806|1009161341", "type": 21}},{}),
new(require("app/view/question").QuestionLink)("Vba7irz","",{},{}),
new(require("app/view/question").RelatedQuestionLink)("M3BEqdw","",{"impression_target": {"hash": "related_questions|5789404|1009161341", "type": 21}},{}),
new(require("app/view/question").QuestionLink)("RoIvJm3","",{},{}),
new(require("app/view/question").RelatedQuestionLink)("robneA3","",{"impression_target": {"hash": "related_questions|6943408|1009161341", "type": 21}},{}),
new(require("app/view/question").QuestionLink)("D7cxk13","",{},{}),
new(require("app/view/question").RelatedQuestionLink)("JrcpmkR","",{"impression_target": {"hash": "related_questions|1682671|1009161341", "type": 21}},{}),
new(require("app/view/question").QuestionLink)("nCDHgxU","",{},{}),
new(require("app/view/question").RelatedQuestionLink)("V4JBCsi","",{"impression_target": {"hash": "related_questions|6106954|1009161341", "type": 21}},{}),
new(require("app/view/question").QuestionLink)("qbeADnN","",{},{}),
new(require("app/view/question").RelatedQuestionLink)("ZuqiVNM","",{"impression_target": {"hash": "related_questions|695538|1009161341", "type": 21}},{}),
new(require("app/view/question").QuestionLink)("BarWVM3","",{},{}),
new(require("app/view/question").RelatedQuestionLink)("t612flh","",{"impression_target": {"hash": "related_questions|3637361|1009161341", "type": 21}},{}),
new(require("app/view/question").QuestionLink)("alo73QX","",{},{}),
new(require("app/view/question").RelatedQuestionLink)("X3iT7Uu","",{"impression_target": {"hash": "related_questions|1537050|1009161341", "type": 21}},{}),
new(require("app/view/question").QuestionLink)("KDM6ZTL","",{},{}),
new(require("app/view/topic/topic_list").TopicListItem)("IMftZeq","",{"tid": 1661336, "remove_tooltip_text": "Remove", "qid": 4785265},{}),
new(require("view/hover_menu").HoverMenu)("Cm83j8W","",{"css_positioning": false, "on": null, "load_on_pageload": false, "should_preload_menu": false, "alignment": "left", "attach_to_body": true, "kwargs": {"tid": 1661336}, "click_open": false, "should_show_hover_menu": true, "show_menu": true},{}),
new(require("app/view/topic").TopicTrendingIndicator)("N4WaaRu","",{"tooltipText": "Trending"},{}),
new(require("app/view/topic/topic_list").TopicListItem)("axxxHc0","",{"tid": 22932, "remove_tooltip_text": "Remove", "qid": 4785265},{}),
new(require("view/hover_menu").HoverMenu)("PsWd8ei","",{"css_positioning": false, "on": null, "load_on_pageload": false, "should_preload_menu": false, "alignment": "left", "attach_to_body": true, "kwargs": {"tid": 22932}, "click_open": false, "should_show_hover_menu": true, "show_menu": true},{}),
new(require("app/view/topic").TopicTrendingIndicator)("fNmmtDg","",{"tooltipText": "Trending"},{}),
new(require("app/view/topic/topic_list").TopicListItem)("DgzKYMv","",{"tid": 3528, "remove_tooltip_text": "Remove", "qid": 4785265},{}),
new(require("view/hover_menu").HoverMenu)("ENGc9F8","",{"css_positioning": false, "on": null, "load_on_pageload": false, "should_preload_menu": false, "alignment": "left", "attach_to_body": true, "kwargs": {"tid": 3528}, "click_open": false, "should_show_hover_menu": true, "show_menu": true},{}),
new(require("app/view/topic").TopicTrendingIndicator)("pOlGQJY","",{"tooltipText": "Trending"},{}),
new(require("app/view/topic/topic_list").TopicListItem)("itUB0av","",{"tid": 5143, "remove_tooltip_text": "Remove", "qid": 4785265},{}),
new(require("view/hover_menu").HoverMenu)("wh85suQ","",{"css_positioning": false, "on": null, "load_on_pageload": false, "should_preload_menu": false, "alignment": "left", "attach_to_body": true, "kwargs": {"tid": 5143}, "click_open": false, "should_show_hover_menu": true, "show_menu": true},{}),
new(require("app/view/topic").TopicTrendingIndicator)("Mu4UFW8","",{"tooltipText": "Trending"},{}),
new(require("app/view/topic/topic_list").TopicListItem)("WyQHWyA","",{"tid": 815, "remove_tooltip_text": "Remove", "qid": 4785265},{}),
new(require("view/hover_menu").HoverMenu)("tTdLROG","",{"css_positioning": false, "on": null, "load_on_pageload": false, "should_preload_menu": false, "alignment": "left", "attach_to_body": true, "kwargs": {"tid": 815}, "click_open": false, "should_show_hover_menu": true, "show_menu": true},{}),
new(require("app/view/topic").TopicTrendingIndicator)("B4nZg7s","",{"tooltipText": "Trending"},{}),
new(require("action_log").ActionableComponent)("rzhG6vF","",{"impression_target": {"hash": "answer_ranking|-836773321", "type": 4}},{}),
new(require("app/view/question").AnswerPagedListItem)("dWQQYNj","",{"view_tracking_hash": "06e0d295be12bd520c05ae26bdd4e913", "view_tracking_key": "a-14458715"},{}),
new(require("app/view/question").RelatedQuestionsList)("RpKMmbx","",{},{}),
new(require("app/view/question").RelatedQuestionLink)("msGHAEE","",{"impression_target": {"hash": "related_questions|4143207|1009161341", "type": 21}},{}),
new(require("app/view/question").QuestionLink)("VnxZBBD","",{},{}),
new(require("app/view/question").RelatedQuestionLink)("Tdt30LI","",{"impression_target": {"hash": "related_questions|2400357|1009161341", "type": 21}},{}),
new(require("app/view/question").QuestionLink)("yNgeMMP","",{},{}),
new(require("app/view/question").RelatedQuestionLink)("bGXbcIe","",{"impression_target": {"hash": "related_questions|2228847|1009161341", "type": 21}},{}),
new(require("app/view/question").QuestionLink)("hBJJwuF","",{},{}),
new(require("app/view/question").RelatedQuestionLink)("wOt8Psp","",{"impression_target": {"hash": "related_questions|5563903|1009161341", "type": 21}},{}),
new(require("app/view/question").QuestionLink)("wj6xKGt","",{},{}),
new(require("app/view/question").RelatedQuestionLink)("pnLTeif","",{"impression_target": {"hash": "related_questions|854479|1009161341", "type": 21}},{}),
new(require("app/view/question").QuestionLink)("EozIeYc","",{},{}),
new(require("action_log").ActionableComponent)("G0A5av7","",{"impression_target": {"hash": "answer_ranking|-1425990055", "type": 4}},{}),
new(require("app/view/question").AnswerPagedListItem)("I0UAPcx","",{"view_tracking_hash": "b30f5d82480ab9879a44872325266d60", "view_tracking_key": "a-14458033"},{}),
new(require("action_log").ActionableComponent)("S8Wnt3v","",{"impression_target": {"hash": null, "type": 4}},{}),
new(require("app/view/question").AnswerPagedListItem)("CIlCmdY","",{"view_tracking_hash": "b9f81da0a0bb7c4ff6b514670851fd6e", "view_tracking_key": "a-4785265"},{}),
new(require("unified_view/toggle").ToggleBase)("c0X55t7","",{"switch_hide": "@_truncated", "key_combination": null, "switch_show": "@_expanded", "log_switch_time": false, "switch_on": ["click", "@link"], "loading_hide": "@loadinghide", "fetch_on": ["click", "@link"], "fetch_into": "@_expanded", "loading_show": "@loadingshow", "serialized_args": "00010000809929ed4f9013486fbdaa73e35b8b03ea8fdde321445cfbaf1cad0e49cff6c4864448b7decad4cab641cdd85e6729fd48a053d56c7add179c1c0ef00d2d0abfc02d02a639f8185ec2f5c3e7c8e348ee4cca0e588610d6767e19b510c040d3cd84560c154efdb4bcf8f33deb7ac3d87679c1c9c636b21f02e0502d854095baf56a06da4aa30a83cab36f3ea2b3051d1a56b9be97b6513690aa29c5cfa805c67ace11c4ec74b292e8a6b13b8d474c13aa906c62fe266b4a6ec31aef820a9f08f9fa43836da6dfe0840c8791b8f45f05f23ed60f55efc5e4695e14c08fde03ceae"},{}),
new(require('app/view/question').AnswerActions)("e2HlV0l","",{},{"js_key": "ba654111a28da919b52f945f87a35ad1"}),
new(require('app/view/question').AnswerActions)("cIoKsMy","",{},{"js_key": "7d0a173a83be76f9bd7ba4ce701135a8"}),
new(require("app/view/components").AnswerHeader)("Eoi9UHN","",{"optimistic_for_web": true},{}),
new(require("view/hover_menu").HoverMenu)("aOkuXmR","",{"css_positioning": false, "on": null, "load_on_pageload": false, "should_preload_menu": false, "alignment": "left", "attach_to_body": true, "kwargs": {"qid": 4785265, "uid": 5010980, "aid": 14458715}, "click_open": false, "should_show_hover_menu": true, "show_menu": true},{}),
new(require("view/user").UserPhoto)("KE0m9vE","",{},{}),
new(require("app/view/user/profile").VerificationBadge)("lXMNk5I","",{"tooltip_text": "Verified profile"},{}),
new(require("view/user").Name)("sXZST77","",{"css_positioning": false, "on": null, "load_on_pageload": false, "should_preload_menu": false, "alignment": "left", "attach_to_body": true, "kwargs": {"qid": 4785265, "uid": 5010980, "aid": 14458715}, "click_open": false, "should_show_hover_menu": true, "show_menu": true},{}),
new(require("app/view/components").QtextTruncate)("VA5cSFB","",{"show_more": false, "was_truncated": false},{}),
new(require("app/view/components").ExpandedQText)("c8cvoxw","",{},{}),
new(require("app/view/components").AnswerHeader)("dbr2CCR","",{"optimistic_for_web": true},{}),
new(require("view/hover_menu").HoverMenu)("CB0mH7Z","",{"css_positioning": false, "on": null, "load_on_pageload": false, "should_preload_menu": false, "alignment": "left", "attach_to_body": true, "kwargs": {"qid": 4785265, "uid": 554801, "aid": 14458033}, "click_open": false, "should_show_hover_menu": true, "show_menu": true},{}),
new(require("view/user").UserPhoto)("oY4kaDI","",{},{}),
new(require("app/view/user/profile").VerificationBadge)("v6PP3WT","",{"tooltip_text": "Verified profile"},{}),
new(require("view/user").Name)("oXiLx8K","",{"css_positioning": false, "on": null, "load_on_pageload": false, "should_preload_menu": false, "alignment": "left", "attach_to_body": true, "kwargs": {"qid": 4785265, "uid": 554801, "aid": 14458033}, "click_open": false, "should_show_hover_menu": true, "show_menu": true},{}),
new(require("app/view/components").QtextTruncate)("zmDRHWU","",{"show_more": false, "was_truncated": false},{}),
new(require("app/view/components").ExpandedQText)("c8yaR92","",{},{}),
new(require("app/view/question/answer_credibility").EndorsementAndAnswerFact)("DwGqDoZ","",{"tid": 3528, "author_public_uid": 5010980},{}),
new(require("view/user").Name)("F0Z9Gir","",{"css_positioning": false, "on": null, "load_on_pageload": false, "should_preload_menu": false, "alignment": "left", "attach_to_body": true, "kwargs": {"qid": 4785265, "uid": 5010980, "aid": 14458715}, "click_open": false, "should_show_hover_menu": true, "show_menu": true},{}),
new(require("view/hover_menu").HoverMenu)("GYSl6Cv","",{"css_positioning": false, "on": null, "load_on_pageload": false, "should_preload_menu": false, "alignment": "left", "attach_to_body": true, "kwargs": {"tid": 3528}, "click_open": false, "should_show_hover_menu": true, "show_menu": true},{}),
new(require("app/view/question").AnswerPermaLink)("IOas4bp","",{},{}),
new(require("unified_view/datetime_").DateTimeComponent)("gqAc3O8","",{"epoch_us": 1438371146384013, "js_disp": false, "granularity": null, "js_update_interval": 0},{}),
new(require('view/voter_list').VoterListModalLink)("IBRzVti","",{"object_id": 14458715},{}),
new(require("app/view/components").TruncatePhraseList)("JJ8jy4M","",{},{}),
new(require("view/user").Name)("zUmESsG","",{"css_positioning": false, "on": null, "load_on_pageload": false, "should_preload_menu": false, "alignment": "left", "attach_to_body": true, "kwargs": {"qid": 4785265, "uid": 4202066, "aid": 14458715}, "click_open": false, "should_show_hover_menu": true, "show_menu": true},{}),
new(require("app/view/question").AnswerPermaLink)("HpaYcRU","",{},{}),
new(require("unified_view/datetime_").DateTimeComponent)("WLqOqdK","",{"epoch_us": 1438368909467354, "js_disp": false, "granularity": null, "js_update_interval": 0},{}),
new(require('view/voter_list').VoterListModalLink)("bVz5PGF","",{"object_id": 14458033},{}),
new(require("app/view/components").TruncatePhraseList)("hQEFdz4","",{},{}),
new(require("view/user").Name)("YfE0GoW","",{"css_positioning": false, "on": null, "load_on_pageload": false, "should_preload_menu": false, "alignment": "left", "attach_to_body": true, "kwargs": {"qid": 4785265, "uid": 4202066, "aid": 14458033}, "click_open": false, "should_show_hover_menu": true, "show_menu": true},{})];
W2.registerComponents(_components);
                    W2.onLoad(_components, true);
                    if (window.w2_timing)
                        w2_timing.logTime('componentInitEnd');
            
            (function() {
                require('shared/w2.timing').logTime('postOnLoad');
                var timing = require('shared/w2.timing').timing;
                $.whenLoaded(1, function() {
            })})();});});</script><script type="text/javascript">require.whenReady("shared/main-loaded",function(){require("shared/main-loaded");
require.enqueue(function(require) {
    var twRootNode = document.createElement("div");
    twRootNode.setAttribute("id", "tw-root");
    document.body.appendChild(twRootNode);
    require("twitter").asyncInit();
});
require('shared/win.load').add(function() {
(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
})(window,document,'script','//www.google-analytics.com/analytics.js','ga');
ga('create', 'UA-16618355-1', 'auto', {'sampleRate': 1});
ga('require', 'displayfeatures');
ga('send', 'pageview');
ga('set', 'dimension1', 'Question');
ga('set', 'dimension2', 'False');
ga('set', 'dimension3', 'False');});});</script><div id="tw-root"></div><script type="text/javascript">require.whenReady(["jquery","shared/main-loaded"],function(){require("jquery");require("shared/main-loaded");
            require.enqueue(function(require) {
                $(document).ready(function() {
                    require('shared/w2.timing').logTime('documentReady');
                });
                $(window).load(function() {
                    var timing = require('shared/w2.timing').timing;
                    require('shared/w2.timing').logTime('windowLoad');
            
timing.server_time = 244.00;
timing.window_id = "dep2508-658848286276270328";    });});

var timing = require("shared/w2.timing").timing;
timing.page = 244.00;
timing.request = 264.98;
timing.page_size = 88598;});</script></body></html><!--perf-->